Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CASQ2,Calsequestrin-2,Lifestyle factors,X1050.Time spend outdoors in summer,46709,0.0153236375202313,0.0303733359906583,-0.044208101021459,0.0748553760619215,0.613909504535673
CASQ2,Calsequestrin-2,Lifestyle factors,X1060.Time spent outdoors in winter,44902,-0.0126063966406946,0.0333235169194778,-0.0779204898028711,0.0527076965214818,0.705210215502346
CASQ2,Calsequestrin-2,Physical activities,X1070.Time spent watching television (TV),47431,-0.0306277943609597,0.0293700651596541,-0.0881931220738817,0.0269375333519624,0.297043429846539
CASQ2,Calsequestrin-2,Physical activities,X1080.Time spent using computer,44904,-0.0352637188940468,0.0300066399327884,-0.0940767331623121,0.0235492953742185,0.239932997636411
CASQ2,Calsequestrin-2,Physical activities,X1090.Time spent driving,42684,-0.0146556294423276,0.0324254931833079,-0.0782095960816111,0.0488983371969559,0.651291350559084
CASQ2,Calsequestrin-2,Lifestyle factors,X1160.Sleep duration,48319,0.000557981770260178,0.0270560022903408,-0.0524717827188079,0.0535877462593282,0.983546429652137
CASQ2,Calsequestrin-2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34628,-0.0165634310080044,0.0212348124429574,-0.058183663396201,0.0250568013801922,0.435413813668666
CASQ2,Calsequestrin-2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34628,-0.00513140621879641,0.0236482745346761,-0.0514820243067616,0.0412192118691688,0.828224564739247
CASQ2,Calsequestrin-2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34628,0.00169751379921976,0.0249539262981965,-0.0472121817452455,0.050607209343685,0.945767256904133
CASQ2,Calsequestrin-2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34628,-0.00323935498867966,0.0258655787400649,-0.0539358893192069,0.0474571793418476,0.900339260514289
CASQ2,Calsequestrin-2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34628,0.0046047923399218,0.0260671988965077,-0.0464869174972334,0.055696502177077,0.859788599215317
CASQ2,Calsequestrin-2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34628,0.0243676727809983,0.0726278321027169,-0.117982878140327,0.166718223702323,0.737248871323781
CASQ2,Calsequestrin-2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34628,-0.0473139634489015,0.0835618687542534,-0.211095226207238,0.116467299309435,0.571268875529284
CASQ2,Calsequestrin-2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34628,-0.0603062487896429,0.0420544821162124,-0.142733033737419,0.0221205361581333,0.151623308278056
CASQ2,Calsequestrin-2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34628,0.0109817863781638,0.03295350880259,-0.0536070908749127,0.0755706636312403,0.738956491302226
CASQ2,Calsequestrin-2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34628,-0.026833436040619,0.0215254622210983,-0.0690233419939716,0.0153564699127336,0.212596136283571
CASQ2,Calsequestrin-2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34628,-0.0120390045338484,0.0346635071441406,-0.0799794785363641,0.0559014694686673,0.728370090038918
CASQ2,Calsequestrin-2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34628,0.0112781396845791,0.0161188882968523,-0.0203148813772514,0.0428711607464095,0.484151226165538
CASQ2,Calsequestrin-2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34628,0.0339327162069522,0.0218451575244371,-0.00888379254094461,0.076749224954849,0.120397057635773
CASQ2,Calsequestrin-2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34628,-0.0354843559261656,0.0352357374985288,-0.104546401423282,0.0335776895709508,0.31394835291082
CASQ2,Calsequestrin-2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34628,-0.00550654689836686,0.0319594870863129,-0.0681471415875401,0.0571340477908064,0.863209257357889
CASQ2,Calsequestrin-2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34628,-0.013751892973225,0.0394695644745367,-0.0911122393433168,0.0636084533968669,0.727538715122749
CASQ2,Calsequestrin-2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34628,0.0536015732625723,0.0391685871283042,-0.023168857508904,0.130372004034049,0.171211718186424
CASQ2,Calsequestrin-2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34628,-0.0417477770711345,0.0246236181791809,-0.0900100687023292,0.0065145145600601,0.090044320066962
CASQ2,Calsequestrin-2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34628,-0.0225273801045156,0.024068768248935,-0.0697021658724283,0.0246474056633971,0.349331794903523
CASQ2,Calsequestrin-2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34628,-0.0721247142325391,0.0265889214056593,-0.124239000187631,-0.0200104282774468,0.00669501520948539
CASQ2,Calsequestrin-2,Health and medical history,X120040.Fatigue severity over the past week,34636,-0.0284552713688032,0.0490371741682525,-0.124568132738578,0.0676575900009716,0.561747756364059
CASQ2,Calsequestrin-2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34638,0.0121451568407097,0.0479941066885866,-0.08192329226892,0.10621360595034,0.800234198124467
CASQ2,Calsequestrin-2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34637,0.0180525685968772,0.0526437120826832,-0.085129107085182,0.121234244278936,0.73167077674142
CASQ2,Calsequestrin-2,Health and medical history,X120098.Mobility problems today,34639,0.0495205464670426,0.0542677632533211,-0.0568442695094667,0.155885362443552,0.36153025772318
CASQ2,Calsequestrin-2,Health and medical history,X120099.Self-care problems today,34639,-0.0410228569252629,0.089912761261142,-0.217251868997101,0.135206155146575,0.648225353276241
CASQ2,Calsequestrin-2,Health and medical history,X120100.Problems doing usual activities,34639,-0.0217358350624874,0.0546454768718189,-0.128840969731252,0.0853692996062777,0.690820494164236
CASQ2,Calsequestrin-2,Health and medical history,X120101.Pain or discomfort today,34639,-0.0540059581392668,0.0487585275549093,-0.149572672146889,0.0415607558683554,0.268069762295246
CASQ2,Calsequestrin-2,Health and medical history,X120102.Anxiety or depression today,34639,-0.0493893417389011,0.064772694749887,-0.17634382344868,0.0775651399708775,0.445789946554957
CASQ2,Calsequestrin-2,Health and medical history,X120103.Scale to indicate how health is today,34625,0.00268603225334507,0.0069792280220517,-0.0109932546698763,0.0163653191765664,0.700354031146885
CASQ2,Calsequestrin-2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34626,0.00207931366329002,0.0613168499214126,-0.118101712182679,0.122260339509259,0.972949271466649
CASQ2,Calsequestrin-2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34624,-0.143711269863905,0.0719481069144342,-0.284729559416196,-0.00269298031161438,0.045823460016298
CASQ2,Calsequestrin-2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34628,0.00663420174841144,0.0486211596655995,-0.0886632711961635,0.101931674692986,0.891472634923069
CASQ2,Calsequestrin-2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34633,-0.0236396515108251,0.0500938518288263,-0.121823601095325,0.0745442980736744,0.637010070402193
CASQ2,Calsequestrin-2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34632,-0.0225290129430593,0.0728573044766528,-0.165329329717299,0.12027130383118,0.757164058212088
CASQ2,Calsequestrin-2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34622,-0.0623659832371634,0.0719470205445504,-0.203382143504482,0.0786501770301554,0.386068587227598
CASQ2,Calsequestrin-2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34637,-0.0304157887256769,0.0668542273970416,-0.161450074423878,0.100618496972525,0.649156647165399
CASQ2,Calsequestrin-2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34632,-0.048778943114728,0.104561668867535,-0.253719814095097,0.156161927865641,0.64086817239355
CASQ2,Calsequestrin-2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34598,-0.179018052633728,0.159221265371416,-0.491091732761703,0.133055627494248,0.26091591415308
CASQ2,Calsequestrin-2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",32330,-0.0629769896037341,0.0740758157014285,-0.208165588378534,0.0822116091710657,0.395285524583901
CASQ2,Calsequestrin-2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46157,-0.106025089740311,0.0728463477417603,-0.248803931314161,0.036753751833539,0.145559288089981
CASQ2,Calsequestrin-2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,45149,-0.0348414070401317,0.0391732265692326,-0.111620931115828,0.0419381170355642,0.373790934629488
CASQ2,Calsequestrin-2,Diet and food preferences,X1289.Cooked vegetable intake,47530,-0.0498529120792758,0.0284255967928136,-0.105567081793191,0.00586125763463897,0.0794803598904156
CASQ2,Calsequestrin-2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46824,-0.0382748200275793,0.0289333367285612,-0.0949841600155592,0.0184345199604005,0.185897778040801
CASQ2,Calsequestrin-2,Diet and food preferences,X1309.Fresh fruit intake,47417,0.00526652798297636,0.0299344077525208,-0.0534049112119643,0.0639379671779171,0.860346430253089
CASQ2,Calsequestrin-2,Diet and food preferences,X1319.Dried fruit intake,46573,-0.0190223502728544,0.0320923178940566,-0.0819232933452053,0.0438785927994966,0.553363673111107
CASQ2,Calsequestrin-2,Health and medical history,X134.Number of self-reported cancers,48442,-0.0758099989820061,0.0633917690403501,-0.200057866301092,0.04843786833708,0.231751218080632
CASQ2,Calsequestrin-2,Health and medical history,X135.Number of self-reported non-cancer illnesses,48443,-0.0122321652520073,0.0280245987996706,-0.0671603788993616,0.0426960483953471,0.662493557203331
CASQ2,Calsequestrin-2,Health and medical history,"X136.Number of operations, self-reported",48443,0.00923377394003783,0.0274318606173124,-0.0445326728698945,0.0630002207499701,0.736416253791366
CASQ2,Calsequestrin-2,Health and medical history,X137.Number of treatments or medications taken,48443,-0.0228384112746031,0.027598476545311,-0.0769314253034127,0.0312546027542065,0.407949880426121
CASQ2,Calsequestrin-2,Diet and food preferences,X1438.Bread intake,47987,-0.000634897522935389,0.00356391568159928,-0.00762017225886997,0.0063503772129992,0.858610134258539
CASQ2,Calsequestrin-2,Diet and food preferences,X1458.Cereal intake,47420,0.0116848403962109,0.0283378758775208,-0.0438573963237298,0.0672270771161516,0.680094913990972
CASQ2,Calsequestrin-2,Diet and food preferences,X1488.Tea intake,47696,0.00311167749152752,0.00353446602659656,-0.00381587592060173,0.0100392309036568,0.378663909243164
CASQ2,Calsequestrin-2,Diet and food preferences,X1498.Coffee intake,46901,-0.0431179214533518,0.0286727612048774,-0.0993165334149116,0.0130806905082079,0.132651716577853
CASQ2,Calsequestrin-2,Diet and food preferences,X1528.Water intake,46689,0.012241177430222,0.0290732249336167,-0.0447423434396668,0.0692246983001107,0.673726184241534
CASQ2,Calsequestrin-2,Lifestyle factors,X1568.Average weekly red wine intake,43709,-0.0445036116950947,0.0318576292470619,-0.106944565019336,0.0179373416291467,0.162448213949553
CASQ2,Calsequestrin-2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,43712,-0.0245982963896653,0.0331646848373667,-0.0896010786709039,0.0404044858915734,0.458279739708901
CASQ2,Calsequestrin-2,Lifestyle factors,X1588.Average weekly beer plus cider intake,43768,0.0231900136106831,0.0333088716814094,-0.0420953748848793,0.0884754021062456,0.486307166337379
CASQ2,Calsequestrin-2,Lifestyle factors,X1598.Average weekly spirits intake,43709,0.0303415877043673,0.0336780772478437,-0.0356674437014064,0.096350619110141,0.367639938642313
CASQ2,Calsequestrin-2,Lifestyle factors,X1608.Average weekly fortified wine intake,43742,0.0495296516673409,0.0582695021499773,-0.0646785725466146,0.163737875881296,0.395333041977693
CASQ2,Calsequestrin-2,Lifestyle factors,X1737.Childhood sunburn occasions,43249,-0.0249146327637255,0.0336892085269232,-0.090945481476495,0.0411162159490441,0.459588930461112
CASQ2,Calsequestrin-2,Health and medical history,X1807.Father's age at death,43344,-0.00418897360135124,0.00405785406604674,-0.0121423675708029,0.00376442036810037,0.301942665203232
CASQ2,Calsequestrin-2,Health and medical history,X1845.Mother's age,35955,0.0089351601473552,0.00917714576421093,-0.00905204555049824,0.0269223658452086,0.330271453686723
CASQ2,Calsequestrin-2,Health and medical history,X1873.Number of full brothers,48104,0.0181773858420063,0.0275355200464819,-0.0357922334490982,0.0721470051331108,0.509169745385256
CASQ2,Calsequestrin-2,Health and medical history,X1883.Number of full sisters,48105,-0.0326148950633128,0.0275444263638206,-0.0866019707364011,0.0213721806097755,0.236394522924217
CASQ2,Calsequestrin-2,Physical measures,X20015.Sitting height,48268,-0.00358865764051663,0.00459620689090121,-0.012597223146683,0.00541990786564975,0.434937299848363
CASQ2,Calsequestrin-2,Cognitive function,X20016.Fluid intelligence score,35020,-0.0265025664333238,0.0453048832659442,-0.115300137634574,0.0622950047679268,0.558580042598667
CASQ2,Calsequestrin-2,Cognitive function,X20018.Prospective memory result,35311,-0.0575905820610726,0.0640677386494583,-0.183163349814011,0.0679821856918656,0.368737419919653
CASQ2,Calsequestrin-2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),34946,-0.00459620693245849,0.00625181184007498,-0.0168497581390054,0.00765734427408847,0.462257054819194
CASQ2,Calsequestrin-2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),34949,-0.00372449663504164,0.00624097272661903,-0.0159568031792149,0.00850780990913165,0.550674595885064
CASQ2,Calsequestrin-2,Cognitive function,X20023.Mean time to correctly identify matches,48195,-0.002789385618703,0.00361443846241024,-0.00987368500502708,0.00429491376762107,0.440281202665046
CASQ2,Calsequestrin-2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45554,-0.00633560105699824,0.00801129741906421,-0.0220377439983641,0.0093665418843676,0.429052316787022
CASQ2,Calsequestrin-2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45187,0.00565616170261038,0.0178448876243707,-0.0293198180411561,0.0406321414463769,0.751275981845291
CASQ2,Calsequestrin-2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45153,0.0352405970579621,0.0235756789334854,-0.0109677336516692,0.0814489277675935,0.134989338763808
CASQ2,Calsequestrin-2,Health and medical history,X20107#12.Illnesses of father_Severe depression,45173,-0.0159296737551938,0.0210583895057727,-0.0572041171865083,0.0253447696761207,0.449388626444555
CASQ2,Calsequestrin-2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45193,-0.00189221628010011,0.0142260713040084,-0.0297753160359567,0.0259908834757564,0.894186721487213
CASQ2,Calsequestrin-2,Health and medical history,X20107#2.Illnesses of father_Stroke,45338,0.000861577066851035,0.0102316111522306,-0.019192380791521,0.020915534925223,0.93289256557661
CASQ2,Calsequestrin-2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45298,-0.00225987792788263,0.0129354615316232,-0.0276133825298641,0.0230936266740988,0.861314278484805
CASQ2,Calsequestrin-2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45201,-0.00753795060622808,0.0157311765170098,-0.0383710565795672,0.0232951553671111,0.631822072856163
CASQ2,Calsequestrin-2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45313,0.0104857478617641,0.0120794385291829,-0.0131899516554344,0.0341614473789625,0.385370758461939
CASQ2,Calsequestrin-2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45387,-0.010177637305276,0.00908413158491488,-0.0279825352117092,0.00762726060115713,0.262569863445006
CASQ2,Calsequestrin-2,Health and medical history,X20107#9.Illnesses of father_Diabetes,45263,0.00204699943268197,0.0124451454730123,-0.0223454856944221,0.026439484559786,0.869353899562877
CASQ2,Calsequestrin-2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46189,0.00707818629485122,0.00955883919119217,-0.0116571385198854,0.0258135111095879,0.459015056460648
CASQ2,Calsequestrin-2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46065,-0.0288158379785247,0.0133806789397364,-0.0550419687004081,-0.00258970725664141,0.0312898447754877
CASQ2,Calsequestrin-2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45996,-0.0237717515889101,0.0300211634450009,-0.0826132319411118,0.0350697287632916,0.428468783190358
CASQ2,Calsequestrin-2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46026,0.015825259141063,0.015827985225395,-0.0151975919007112,0.0468481101828372,0.317407748231016
CASQ2,Calsequestrin-2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46145,0.00611043118277163,0.0107563287283788,-0.0149719731248508,0.027192835490394,0.569989434850334
CASQ2,Calsequestrin-2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46066,0.00765833059574724,0.0180030174590618,-0.027627583624014,0.0429442448155085,0.670556542556527
CASQ2,Calsequestrin-2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46032,0.0219386215131163,0.0162949742136354,-0.00999952794560905,0.0538767709718416,0.178209488742309
CASQ2,Calsequestrin-2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46039,0.0045831401900542,0.0137797186331194,-0.0224251083308598,0.0315913887109682,0.739439924919743
CASQ2,Calsequestrin-2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46070,-0.019642331579314,0.0162362681836087,-0.0514654172191871,0.0121807540605591,0.226379241857021
CASQ2,Calsequestrin-2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46244,-0.00296877155394389,0.00821329524937356,-0.0190668302427161,0.0131292871348283,0.717760489344774
CASQ2,Calsequestrin-2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46116,0.00212774824346677,0.0123365383183887,-0.0220518668605751,0.0263073633475087,0.863065864678038
CASQ2,Calsequestrin-2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43666,0.000413098717589814,0.0131796217022391,-0.0254189598187987,0.0262451572539784,0.974995818298405
CASQ2,Calsequestrin-2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43544,-0.0208933092421384,0.0538639160829186,-0.126466584764659,0.0846799662803822,0.698102484970191
CASQ2,Calsequestrin-2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43540,0.0407721093462725,0.0516538420144206,-0.0604694210019919,0.142013639694537,0.429929621814094
CASQ2,Calsequestrin-2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43588,-0.0080695792440659,0.0171903166556402,-0.0417625998891207,0.0256234414009889,0.638772093590998
CASQ2,Calsequestrin-2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43551,-0.0492613587468285,0.0308018815825272,-0.109633046648582,0.0111103291549249,0.109775741976194
CASQ2,Calsequestrin-2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43584,0.0108699462721663,0.0219249387652669,-0.0321029337077568,0.0538428262520894,0.620056904089741
CASQ2,Calsequestrin-2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43557,-0.0214091122044216,0.0251316031854856,-0.0706670544479734,0.0278488300391303,0.394294291582924
CASQ2,Calsequestrin-2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43564,-0.016145750219221,0.0244368185213925,-0.0640419145211504,0.0317504140827084,0.508805859551689
CASQ2,Calsequestrin-2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43569,0.00887076541803765,0.0193262553217146,-0.029008695012523,0.0467502258485983,0.646240302152571
CASQ2,Calsequestrin-2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43585,-0.0332561690428123,0.0244152005759937,-0.0811099621717599,0.0145976240861353,0.173183903007964
CASQ2,Calsequestrin-2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43721,0.000135997951881332,0.0100285710631368,-0.0195200013318668,0.0197919972356294,0.989180358254744
CASQ2,Calsequestrin-2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43639,0.0148330452221074,0.0139294353908469,-0.0124686481439524,0.0421347385881673,0.286951619752694
CASQ2,Calsequestrin-2,Mental health,X20127.Neuroticism score,44564,-0.0530927967039363,0.0286409729742727,-0.109229103733511,0.00304351032563819,0.0637954154304047
CASQ2,Calsequestrin-2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35020,-0.017794996279595,0.0454420853648606,-0.106861483594722,0.0712714910355319,0.695368829216812
CASQ2,Calsequestrin-2,Lifestyle factors,X20161.Pack years of smoking,35600,0.0147219367279079,0.00619714163174596,0.00257553912968579,0.02686833432613,0.0175471568447076
CASQ2,Calsequestrin-2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,35600,0.0159554986173318,0.00611350552835997,0.00397302778174625,0.0279379694529173,0.00907675914528725
CASQ2,Calsequestrin-2,Cognitive function,X20191.Fluid intelligence score,33176,0.0215389218083567,0.051829220783438,-0.0800463509271818,0.123124194543895,0.677740653893795
CASQ2,Calsequestrin-2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,33177,0.0109647894953028,0.0534821680338214,-0.093860259850987,0.115789838841593,0.837567459865996
CASQ2,Calsequestrin-2,Cognitive function,X20240.Maximum digits remembered correctly,32746,-0.028619270256022,0.0578388525180752,-0.141983421191449,0.0847448806794055,0.620760177410684
CASQ2,Calsequestrin-2,Physical measures,X20255.Spirometry QC measure,42729,-0.0199442344063927,0.034471072097551,-0.0875075357175926,0.0476190669048072,0.562882577452897
CASQ2,Calsequestrin-2,Eye measures,X20261.avMSE,33046,-0.00705975189663688,0.00787165242672595,-0.0224881906530198,0.00836868685974598,0.369843426325371
CASQ2,Calsequestrin-2,Eye measures,X20262.Myopia diagnosis,33046,0.128862607811235,0.0631393771905642,0.0051094285177293,0.252615787104741,0.0413174316347321
CASQ2,Calsequestrin-2,NMR metabolomics,X20280.Glucose-lactate,39552,-0.0016798372337767,0.00456120805283838,-0.0106198050173399,0.00726013054978652,0.71266577378583
CASQ2,Calsequestrin-2,NMR metabolomics,X20281.Spectrometer-corrected alanine,39572,-0.00437171224097879,0.00482262898114949,-0.0138240650440318,0.00508064056207421,0.364691273720236
CASQ2,Calsequestrin-2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,34696,-0.021921282447093,0.0293635679753641,-0.0794738756788066,0.0356313107846207,0.455365863899515
CASQ2,Calsequestrin-2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,34696,-0.10704864123038,0.0654901872688468,-0.23540940827732,0.0213121258165598,0.102189746927544
CASQ2,Calsequestrin-2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),34699,-0.0138590170451629,0.077619924167989,-0.165994068414421,0.138276034324096,0.858297194521462
CASQ2,Calsequestrin-2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),34699,0.0106497107644676,0.0283826105580425,-0.0449802059292956,0.0662796274582309,0.707510228839284
CASQ2,Calsequestrin-2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),34699,-0.0529972789718256,0.0401197404947714,-0.131631970341578,0.0256374123979263,0.186558388111758
CASQ2,Calsequestrin-2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,34700,-0.0278492354170318,0.0554123247740349,-0.13645739197414,0.0807589211400766,0.615276350245098
CASQ2,Calsequestrin-2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,34700,-0.0295119792887918,0.036562824129375,-0.101175114582367,0.0421511560047833,0.419606878337257
CASQ2,Calsequestrin-2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,34700,-0.050153226699609,0.0402927832138454,-0.129127081798746,0.028820628399528,0.213282568789584
CASQ2,Calsequestrin-2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,34700,0.00998788470384187,0.0585765019295736,-0.104822059078122,0.124797828485806,0.864614653598572
CASQ2,Calsequestrin-2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,34700,-0.0613801962513273,0.0649140924073015,-0.188611817369638,0.0658514248669836,0.344410293682876
CASQ2,Calsequestrin-2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,34700,-0.0104839278403397,0.0431044789597504,-0.0949687066014505,0.0740008509207711,0.807842137622857
CASQ2,Calsequestrin-2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,34700,-0.0689753118639081,0.0622408694185818,-0.190967415924329,0.0530167921965122,0.267819279339525
CASQ2,Calsequestrin-2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,34700,-0.0201415310474436,0.049052096695189,-0.116283640570014,0.0760005784751267,0.681369219937179
CASQ2,Calsequestrin-2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),34703,-0.163413711775595,0.0842857010577436,-0.328613685848773,0.00178626229758214,0.0525708792553539
CASQ2,Calsequestrin-2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),34703,-0.0117042405994774,0.0382761894891602,-0.0867255719982314,0.0633170907992766,0.759779654786741
CASQ2,Calsequestrin-2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),34703,-0.0651670634339623,0.0486288211867806,-0.160479552960052,0.0301454260921276,0.180265531400908
CASQ2,Calsequestrin-2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,34703,0.13136159987261,0.103272308753033,-0.0710521252833348,0.333775325028555,0.20342425718157
CASQ2,Calsequestrin-2,Diet and food preferences,X20600.Liking for adding salt to foods,35152,-0.00583397310721629,0.0431641395034925,-0.0904356865340616,0.078767740319629,0.892491214619373
CASQ2,Calsequestrin-2,Diet and food preferences,X20601.Liking for aniseed,35152,0.0464880894597924,0.0432773061794677,-0.0383354306519642,0.131311609571549,0.282776731915027
CASQ2,Calsequestrin-2,Diet and food preferences,X20602.Liking for apple juice,35152,0.0204584323231142,0.0437873075829883,-0.0653646905395429,0.106281555185771,0.640355978160313
CASQ2,Calsequestrin-2,Diet and food preferences,X20603.Liking for apples,35152,0.011453639502827,0.0444439982777282,-0.0756565971215204,0.0985638761271744,0.796639236923411
CASQ2,Calsequestrin-2,Diet and food preferences,X20604.Liking for asparagus,35152,0.0479006281911093,0.0436978050923328,-0.0377470697898629,0.133548326172081,0.273040672833178
CASQ2,Calsequestrin-2,Diet and food preferences,X20605.Liking for aubergine,35152,0.0716312680849461,0.0433961727597588,-0.0134252305241811,0.156687766694073,0.0988609972740716
CASQ2,Calsequestrin-2,Diet and food preferences,X20606.Liking for avocados,35152,0.0373212156531799,0.0430553208835957,-0.0470672132786676,0.121709644585027,0.386072397520353
CASQ2,Calsequestrin-2,Diet and food preferences,X20607.Liking for bacon,35152,-0.0306621703911004,0.0442761331921364,-0.117443391447688,0.0561190506654869,0.488634519088903
CASQ2,Calsequestrin-2,Diet and food preferences,X20608.Liking for baked or steamed fish,35152,0.0553136975165757,0.0433762024749035,-0.0297036593342352,0.140331054367387,0.202280767277142
CASQ2,Calsequestrin-2,Diet and food preferences,X20609.Liking for bananas,35152,0.0110917255421191,0.0453110404297249,-0.0777179137001417,0.0999013647843799,0.806626099089102
CASQ2,Calsequestrin-2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35152,0.00755503838209598,0.0446274842308214,-0.0799148307103139,0.0950249074745058,0.865572865614712
CASQ2,Calsequestrin-2,Diet and food preferences,X20611.Liking for beef steak,35152,-0.0471367701969941,0.0455331519866921,-0.136381748090911,0.0421082076969224,0.300605048302137
CASQ2,Calsequestrin-2,Diet and food preferences,X20612.Liking for beetroot,35152,-0.0266000945840277,0.0443261245832629,-0.113479298767223,0.0602791095991676,0.548460566980889
CASQ2,Calsequestrin-2,Diet and food preferences,X20613.Liking for bell pepper,35152,0.017674612185855,0.0440651118615587,-0.0686930070628,0.10404223143451,0.688357997878668
CASQ2,Calsequestrin-2,Diet and food preferences,X20614.Liking for bicycling,35152,-0.0148912005896187,0.0436800524011395,-0.100504103295852,0.0707217021166148,0.733178250574115
CASQ2,Calsequestrin-2,Diet and food preferences,X20615.Liking for biscuits,35152,0.00732293761882762,0.0451684414580488,-0.081207207638948,0.0958530828766033,0.871212355078753
CASQ2,Calsequestrin-2,Diet and food preferences,X20616.Liking for bitter foods,35152,0.019974011979718,0.0441381425699822,-0.0665367474574471,0.106484771416883,0.65089930762553
CASQ2,Calsequestrin-2,Diet and food preferences,X20617.Liking for bitter or ale,35152,-0.00847409028284586,0.04380336771176,-0.0943286909978956,0.0773805104322038,0.846606687425498
CASQ2,Calsequestrin-2,Diet and food preferences,X20618.Liking for black olives,35152,0.0637213476119992,0.0441738660174605,-0.0228594297822234,0.150302125006222,0.149205754092791
CASQ2,Calsequestrin-2,Diet and food preferences,X20619.Liking for black pepper,35152,-0.0184373950895564,0.0432862568844894,-0.103278458583156,0.0664036684040429,0.670164789092222
CASQ2,Calsequestrin-2,Diet and food preferences,X20620.Liking for blue cheese,35152,0.054568743174771,0.0435618715312271,-0.0308125250264341,0.139950011375976,0.210369814828948
CASQ2,Calsequestrin-2,Diet and food preferences,X20621.Liking for bolognese sauce,35152,0.0131362575752771,0.0435589774881054,-0.0722393383014094,0.0985118534519636,0.762986370881716
CASQ2,Calsequestrin-2,Diet and food preferences,X20622.Liking for broad beans,35152,0.0237984628500162,0.0434642543796456,-0.0613914757340893,0.108988401434122,0.584025762459538
CASQ2,Calsequestrin-2,Diet and food preferences,X20623.Liking for broccoli,35152,0.0630783374320465,0.043435023468914,-0.0220543085670251,0.148210983431118,0.146481176565437
CASQ2,Calsequestrin-2,Diet and food preferences,X20624.Liking for brown rice,35152,0.0602672551301168,0.0439423606874565,-0.0258597718172978,0.146394282077531,0.170263993623195
CASQ2,Calsequestrin-2,Diet and food preferences,X20625.Liking for brussel sprouts,35152,0.0454234396531593,0.0438463171725508,-0.0405153420050402,0.131362221311359,0.30025473820825
CASQ2,Calsequestrin-2,Diet and food preferences,X20626.Liking for burgers (meat),35152,-0.0543509846448425,0.0437377886522324,-0.140077050403218,0.031375081113533,0.214039500381609
CASQ2,Calsequestrin-2,Diet and food preferences,X20627.Liking for burn of spicy foods,35152,-0.0577223605410034,0.0447767537530674,-0.145484797897016,0.0300400768150087,0.197403870533317
CASQ2,Calsequestrin-2,Diet and food preferences,X20628.Liking for butter on bread,35152,0.0738146452548977,0.0456576726285217,-0.0156743930970049,0.1633036836068,0.105991801351368
CASQ2,Calsequestrin-2,Diet and food preferences,X20629.Liking for butternut squash,35152,0.0783876948299369,0.0436324874929723,-0.00713198065628891,0.163907370316163,0.072454109003784
CASQ2,Calsequestrin-2,Diet and food preferences,X20630.Liking for cabbage,35152,0.084215816440236,0.0432140264727277,-0.000483675446310297,0.168915308326782,0.0513611070581989
CASQ2,Calsequestrin-2,Diet and food preferences,X20631.Liking for cake,35152,0.0474936810077899,0.0436858592576268,-0.0381306031371586,0.133117965152738,0.277004510788764
CASQ2,Calsequestrin-2,Diet and food preferences,X20632.Liking for cake icing,35152,0.00828821882667561,0.044537683954462,-0.07900564172407,0.0955820793774212,0.852376409767212
CASQ2,Calsequestrin-2,Diet and food preferences,X20633.Liking for capers,35152,0.0927030194088051,0.0441944156927207,0.00608196465107244,0.179324074166538,0.0359771355594623
CASQ2,Calsequestrin-2,Diet and food preferences,X20634.Liking for cauliflower,35152,0.0124694047452451,0.0432921951853637,-0.0723832978180677,0.0973221073085578,0.773333714908356
CASQ2,Calsequestrin-2,Diet and food preferences,X20635.Liking for cereal or granola bar,35152,0.00583271981855998,0.0439523689585999,-0.0803139233402958,0.0919793629774158,0.894430396768814
CASQ2,Calsequestrin-2,Diet and food preferences,X20636.Liking for cheesecake,35152,-0.0647318163266966,0.0439294894920573,-0.150833615731129,0.0213699830777357,0.140653859417659
CASQ2,Calsequestrin-2,Diet and food preferences,X20637.Liking for cherries,35152,0.0647238349543748,0.0436297850732373,-0.0207905437891703,0.15023821369792,0.137995570490566
CASQ2,Calsequestrin-2,Diet and food preferences,X20638.Liking for chicken,35152,0.0428613620445423,0.0460367811328775,-0.0473707289758975,0.133093453064982,0.35187534282216
CASQ2,Calsequestrin-2,Diet and food preferences,X20639.Liking for chilli pepper,35152,-0.0289881736420245,0.044641028143852,-0.116484588803974,0.0585082415199254,0.516127411307299
CASQ2,Calsequestrin-2,Diet and food preferences,X20640.Liking for chips or french fries,35152,-0.0522132503106041,0.0437953409075336,-0.13805211848937,0.0336256178681617,0.233222088067916
CASQ2,Calsequestrin-2,Diet and food preferences,X20641.Liking for cigarette smoking,35152,0.0345842451894267,0.0696077377670931,-0.101846920834076,0.171015411212929,0.619315166095875
CASQ2,Calsequestrin-2,Diet and food preferences,X20642.Liking for cod,35152,-0.0314523897931575,0.0445440824604208,-0.118758791415582,0.0558540118292672,0.480153700069489
CASQ2,Calsequestrin-2,Diet and food preferences,X20643.Liking for coffee with sugar,35152,0.00653361656658423,0.0452306447282137,-0.0821184471007147,0.0951856802338832,0.885148713656047
CASQ2,Calsequestrin-2,Diet and food preferences,X20644.Liking for coffee without sugar,35152,0.0398372332194378,0.0442941424339307,-0.0469792859510663,0.126653752389942,0.368483777820895
CASQ2,Calsequestrin-2,Diet and food preferences,X20645.Liking for coriander,35152,0.0248040421934067,0.0439542263298665,-0.0613462414131317,0.110954325799945,0.572558917297962
CASQ2,Calsequestrin-2,Diet and food preferences,X20646.Liking for corn flakes,35152,0.00676849045356054,0.0431242195790364,-0.0777549799213508,0.0912919608284719,0.875286461337575
CASQ2,Calsequestrin-2,Diet and food preferences,X20647.Liking for cream,35152,-0.0216745573061322,0.04457025604843,-0.109032259161055,0.0656831445487907,0.626770101344476
CASQ2,Calsequestrin-2,Diet and food preferences,X20648.Liking for croissant,35152,0.023265755203612,0.043583807570161,-0.0621585076339034,0.108690018041128,0.593486637497069
CASQ2,Calsequestrin-2,Diet and food preferences,X20649.Liking for cucumber,35152,0.0363905998551264,0.0426124308440493,-0.0471297645992102,0.119910964309463,0.393141663777516
CASQ2,Calsequestrin-2,Diet and food preferences,X20650.Liking for curry,35152,0.0120574040261686,0.0453897732939644,-0.0769065516300016,0.101021359682339,0.790523748570256
CASQ2,Calsequestrin-2,Diet and food preferences,X20651.Liking for dairy products,35152,0.072364478536942,0.0460795902952167,-0.0179515184416828,0.162680475515567,0.116364937142118
CASQ2,Calsequestrin-2,Diet and food preferences,X20652.Liking for dark chocolate,35152,0.0534670941841049,0.0429184725725594,-0.0306531120581115,0.137587300426321,0.212888758600369
CASQ2,Calsequestrin-2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35152,-0.0327943627397147,0.045119296208164,-0.121228183307716,0.0556394578282867,0.467351968271903
CASQ2,Calsequestrin-2,Diet and food preferences,X20654.Liking for dried fruit,35152,0.0475115763644516,0.0428045099579902,-0.0363852631532091,0.131408415882112,0.267054210480462
CASQ2,Calsequestrin-2,Diet and food preferences,X20655.Liking for eggs,35152,0.0661864507807129,0.0443914222114329,-0.0208207367536955,0.153193638315121,0.136016560132824
CASQ2,Calsequestrin-2,Diet and food preferences,X20656.Liking for exercising alone,35152,0.00761981921186948,0.0436405799769441,-0.0779157175429409,0.0931553559666798,0.861396218594891
CASQ2,Calsequestrin-2,Diet and food preferences,X20657.Liking for exercising with others,35152,0.0609360672992708,0.042965269213557,-0.0232758603593008,0.145147994957842,0.156161513488498
CASQ2,Calsequestrin-2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35152,0.0142605657972347,0.0438685766421751,-0.0717218444214285,0.100242976015898,0.745134905601008
CASQ2,Calsequestrin-2,Diet and food preferences,X20659.Liking for fatty foods,35152,-0.0324779604594015,0.0434202144106741,-0.117581580704323,0.0526256597855197,0.454492040428986
CASQ2,Calsequestrin-2,Diet and food preferences,X20660.Liking for fresh tomatoes,35152,0.0313954611543175,0.0458348103764854,-0.0584407671835939,0.121231689492229,0.493387238352073
CASQ2,Calsequestrin-2,Diet and food preferences,X20661.Liking for fried chicken,35152,-0.0326805831518536,0.0455371683540979,-0.121933433125886,0.0565722668221783,0.472987441874758
CASQ2,Calsequestrin-2,Diet and food preferences,X20662.Liking for fried or battered fish,35152,-0.00416221016677863,0.0450182480280425,-0.0923979763017419,0.0840735559681846,0.926338525469507
CASQ2,Calsequestrin-2,Diet and food preferences,X20663.Liking for fruit,35152,-0.00796059126925262,0.0456413312032018,-0.0974176004275282,0.081496417889023,0.861543715909835
CASQ2,Calsequestrin-2,Diet and food preferences,X20664.Liking for garlic,35152,-0.0210103101263344,0.04325977131737,-0.10579946190838,0.0637788416557108,0.627211896013175
CASQ2,Calsequestrin-2,Diet and food preferences,X20665.Liking for gherkins,35152,0.0550376216010668,0.0436690521272871,-0.030553720568416,0.14062896377055,0.207593593420409
CASQ2,Calsequestrin-2,Diet and food preferences,X20666.Liking for globe artichoke,35152,0.0286513354062983,0.045000797620317,-0.0595502279295231,0.11685289874212,0.52435228194597
CASQ2,Calsequestrin-2,Diet and food preferences,X20667.Liking for goat's cheese,35152,0.0242033584397627,0.0441438043778752,-0.0623184981408728,0.110725215020398,0.583515356124735
CASQ2,Calsequestrin-2,Diet and food preferences,X20668.Liking for going to a cafe,35152,-0.000140952503729032,0.0433833565204876,-0.0851723312838846,0.0848904262764266,0.997407777068323
CASQ2,Calsequestrin-2,Diet and food preferences,X20669.Liking for going to the gym,35152,0.0745675153883967,0.0428317547427097,-0.00938272390731418,0.158517754684108,0.0817410997949446
CASQ2,Calsequestrin-2,Diet and food preferences,X20670.Liking for going to the pub,35152,-0.0293951226746081,0.0425467763110152,-0.112786804244198,0.0539965588949817,0.489659469583462
CASQ2,Calsequestrin-2,Diet and food preferences,X20671.Liking for grapefruit,35152,0.062044379137195,0.0427165149924479,-0.0216799902480028,0.145768748522393,0.146419419677223
CASQ2,Calsequestrin-2,Diet and food preferences,X20672.Liking for green olives,35152,0.0258358257473903,0.0431190520468221,-0.0586775162643811,0.110349167759162,0.549077435852137
CASQ2,Calsequestrin-2,Diet and food preferences,X20673.Liking for haddock,35152,0.0204933037586921,0.0444633697415091,-0.0666549009346657,0.10764150845205,0.644883465826094
CASQ2,Calsequestrin-2,Diet and food preferences,X20674.Liking for ham,35152,-0.0236308804164758,0.0443149844022166,-0.11048824984482,0.0632264890118688,0.593879973697577
CASQ2,Calsequestrin-2,Diet and food preferences,X20675.Liking for hard cheese,35152,-0.0332645753717997,0.0454980210748645,-0.122440696678534,0.0559115459349346,0.464731204987618
CASQ2,Calsequestrin-2,Diet and food preferences,X20676.Liking for herring,35152,0.0119455167891,0.0439664058026566,-0.074228638584107,0.0981196721623069,0.785863995866851
CASQ2,Calsequestrin-2,Diet and food preferences,X20677.Liking for honey,35152,0.0629268128889619,0.0450466410499109,-0.0253646035688636,0.151218229346787,0.162483274704456
CASQ2,Calsequestrin-2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35152,-0.0191190533610184,0.0435411288996171,-0.104459666004268,0.066221559282231,0.660601188325989
CASQ2,Calsequestrin-2,Diet and food preferences,X20679.Liking for ice cream,35152,0.0407140568777529,0.0434305019074308,-0.0444097268608116,0.125837840616317,0.348560159777383
CASQ2,Calsequestrin-2,Diet and food preferences,X20680.Liking for jam,35152,0.0995246621822255,0.0435019758139502,0.0142607895868831,0.184788534777568,0.0221797987648032
CASQ2,Calsequestrin-2,Diet and food preferences,X20681.Liking for kiwi fruit,35152,0.0520349144668005,0.0428968566118385,-0.0320429244924029,0.136112753426004,0.225164454863264
CASQ2,Calsequestrin-2,Diet and food preferences,X20682.Liking for lager,35152,-0.0333737341533609,0.0426344582099501,-0.116937272244863,0.0501898039381412,0.433780057181293
CASQ2,Calsequestrin-2,Diet and food preferences,X20683.Liking for lamb,35152,0.0487421368012495,0.0445977572799061,-0.0386694674673665,0.136153741069865,0.274465659420669
CASQ2,Calsequestrin-2,Diet and food preferences,X20684.Liking for lemons,35152,0.0221242785838816,0.043919265297762,-0.063957481399732,0.108206038567495,0.61445484837622
CASQ2,Calsequestrin-2,Diet and food preferences,X20685.Liking for lentils or beans,35152,0.0509325548636253,0.044062393049863,-0.0354297355141062,0.137294845241357,0.247756518751364
CASQ2,Calsequestrin-2,Diet and food preferences,X20686.Liking for liver,35152,-0.0163536024603856,0.0445113541186412,-0.103595856532922,0.0708886516121512,0.713330360033122
CASQ2,Calsequestrin-2,Diet and food preferences,X20687.Liking for mackerel,35152,0.0742314000223098,0.0436194463662353,-0.0112627148555114,0.159725514900131,0.0888411206724348
CASQ2,Calsequestrin-2,Diet and food preferences,X20688.Liking for marzipan,35152,0.0613077491259029,0.0438076058564325,-0.0245551583527048,0.147170656604511,0.161717313202623
CASQ2,Calsequestrin-2,Diet and food preferences,X20689.Liking for mayonnaise,35152,0.0200950998189668,0.044670731362904,-0.067459533652325,0.107649733290259,0.652833967672341
CASQ2,Calsequestrin-2,Diet and food preferences,X20690.Liking for melon,35152,0.0649950235664727,0.0430646838164014,-0.0194117567136741,0.149401803846619,0.131285271080978
CASQ2,Calsequestrin-2,Diet and food preferences,X20691.Liking for milk chocolate,35152,0.0362627179244058,0.043782078236539,-0.0495501554192107,0.122075591268022,0.407556405714605
CASQ2,Calsequestrin-2,Diet and food preferences,X20692.Liking for mushrooms,35152,0.0690729758528895,0.045020018790784,-0.0191662609770472,0.157312212682826,0.125010982812613
CASQ2,Calsequestrin-2,Diet and food preferences,X20694.Liking for orange juice,35152,-0.00970695035056415,0.0449540193856445,-0.0978168283464274,0.078402927645299,0.829048541104752
CASQ2,Calsequestrin-2,Diet and food preferences,X20695.Liking for oranges,35152,0.0160081932936057,0.0436864717441503,-0.0696172913249289,0.10163367791214,0.714053362321074
CASQ2,Calsequestrin-2,Diet and food preferences,X20696.Liking for pasta,35152,0.0624246623555197,0.0447149912022837,-0.0252167204009562,0.150066045111996,0.162744790072655
CASQ2,Calsequestrin-2,Diet and food preferences,X20697.Liking for pears,35152,0.0104191138936985,0.0447726290937062,-0.0773352391299656,0.0981734669173626,0.815992574865527
CASQ2,Calsequestrin-2,Diet and food preferences,X20698.Liking for pizza,35152,-0.0398012704071452,0.04402959577172,-0.126099278119716,0.046496737305426,0.366046556146464
CASQ2,Calsequestrin-2,Diet and food preferences,X20699.Liking for plain yogurt,35152,0.0717522091933829,0.0436381366021902,-0.0137785385469099,0.157282956933676,0.100171652975999
CASQ2,Calsequestrin-2,Diet and food preferences,X20700.Liking for plums,35152,0.0827987727286262,0.0436497024256749,-0.00275464402569654,0.168352189482949,0.0578861851217771
CASQ2,Calsequestrin-2,Diet and food preferences,X20701.Liking for pollock,35152,-0.00695024798433224,0.0438411084543654,-0.0928788205548885,0.078978324586224,0.874041971685714
CASQ2,Calsequestrin-2,Diet and food preferences,X20702.Liking for pork chop,35152,-0.0252476613473563,0.0447065207943431,-0.112872442104269,0.0623771194095562,0.572268449374493
CASQ2,Calsequestrin-2,Diet and food preferences,X20703.Liking for porridge,35152,0.0613548851336176,0.0439834916443906,-0.0248527584893881,0.147562528756623,0.163077489655799
CASQ2,Calsequestrin-2,Diet and food preferences,X20704.Liking for potato crisps,35152,-0.0328464358381635,0.042923348092741,-0.116976198099936,0.051283326423609,0.444159394654404
CASQ2,Calsequestrin-2,Diet and food preferences,X20705.Liking for potatoes,35152,-0.0416704232724717,0.0456345535013057,-0.131114148135031,0.0477733015900876,0.361206160607583
CASQ2,Calsequestrin-2,Diet and food preferences,X20706.Liking for prawns,35152,-0.0122451305509395,0.0439850306278512,-0.0984557905815279,0.073965529479649,0.780719386252052
CASQ2,Calsequestrin-2,Diet and food preferences,X20707.Liking for raw carrots,35152,0.0308041638754762,0.0430541389178245,-0.0535819484034599,0.115190276154412,0.474341058340214
CASQ2,Calsequestrin-2,Diet and food preferences,X20708.Liking for red meat,35152,-0.00741192265394672,0.0451796546530832,-0.0959640457739897,0.0811402004660963,0.869693359691431
CASQ2,Calsequestrin-2,Diet and food preferences,X20709.Liking for red wine,35152,-0.0509786457389073,0.0439162557081969,-0.137054506926973,0.0350972154491587,0.245759515450149
CASQ2,Calsequestrin-2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35152,-0.00570838878137223,0.0442452209840887,-0.092429021910186,0.0810122443474415,0.89734810714715
CASQ2,Calsequestrin-2,Diet and food preferences,X20711.Liking for roast chicken,35152,0.0102060874605076,0.0460549088166264,-0.0800615338200801,0.100473708741095,0.82462679438823
CASQ2,Calsequestrin-2,Diet and food preferences,X20712.Liking for salad dressing,35152,0.0629126543581378,0.0436435022248173,-0.0226286100025042,0.14845391871878,0.149487803288609
CASQ2,Calsequestrin-2,Diet and food preferences,X20713.Liking for salad leaves,35152,0.0328849015776568,0.0441318532256528,-0.0536135307446227,0.119383333899936,0.456207109670583
CASQ2,Calsequestrin-2,Diet and food preferences,X20714.Liking for salami,35152,0.0266381290512128,0.044128947740514,-0.0598546085201946,0.11313086662262,0.546101964112124
CASQ2,Calsequestrin-2,Diet and food preferences,X20715.Liking for salmon,35152,-0.0148509995670769,0.045241844097767,-0.1035250139987,0.0738230148645464,0.742727062846527
CASQ2,Calsequestrin-2,Diet and food preferences,X20716.Liking for salty foods,35152,0.019106853461454,0.043314797579542,-0.0657901497944482,0.104003856717356,0.659143542192734
CASQ2,Calsequestrin-2,Diet and food preferences,X20717.Liking for salty pretzels,35152,0.0301252171517614,0.0417384042460118,-0.0516820551704218,0.111932489473945,0.470466268368902
CASQ2,Calsequestrin-2,Diet and food preferences,X20718.Liking for sardines,35152,0.0499820014502451,0.0424471863384752,-0.0332144837731664,0.133178486673657,0.239034695765738
CASQ2,Calsequestrin-2,Diet and food preferences,X20719.Liking for sausages (meat),35152,-0.044139836355811,0.0444191463643527,-0.131201363229942,0.0429216905183203,0.320399872340113
CASQ2,Calsequestrin-2,Diet and food preferences,X20720.Liking for savoury biscuits,35152,-0.014651834267687,0.0436392650967948,-0.100184793857405,0.0708811253220308,0.737071009404613
CASQ2,Calsequestrin-2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35152,0.0219722602675814,0.0444562956610614,-0.065162079228099,0.109106599763262,0.621150415563639
CASQ2,Calsequestrin-2,Diet and food preferences,X20722.Liking for skimmed milk,35152,0.0230016406549497,0.0449566629597364,-0.0651134187461336,0.111116700056033,0.608920039427865
CASQ2,Calsequestrin-2,Diet and food preferences,X20723.Liking for smoked fish,35152,0.042960303536155,0.0438671642703138,-0.04301933843366,0.12893994550597,0.327454583812634
CASQ2,Calsequestrin-2,Diet and food preferences,X20724.Liking for soft cheese,35152,0.0514988827404694,0.0445271458640369,-0.0357743231530429,0.138772088633982,0.247489193299855
CASQ2,Calsequestrin-2,Diet and food preferences,X20725.Liking for soy sauce,35152,-0.00263616792634162,0.0429987678468236,-0.0869137529061159,0.0816414170534327,0.9511158020925
CASQ2,Calsequestrin-2,Diet and food preferences,X20726.Liking for soya milk,35152,-0.0229839801011859,0.0447712213008201,-0.110735573850793,0.0647676136484215,0.60771332446858
CASQ2,Calsequestrin-2,Diet and food preferences,X20727.Liking for spicy foods,35152,-0.0353297642517509,0.045326367596036,-0.124169444739981,0.0535099162364797,0.43574122117475
CASQ2,Calsequestrin-2,Diet and food preferences,X20728.Liking for spinach,35152,0.124627873842953,0.0437578999874825,0.0388623898674871,0.210393357818418,0.00441150811560591
CASQ2,Calsequestrin-2,Diet and food preferences,X20729.Liking for spirits,35152,-0.0340072925296791,0.0429322833019503,-0.118154567801502,0.0501399827421435,0.428322518695527
CASQ2,Calsequestrin-2,Diet and food preferences,X20730.Liking for strawberries,35152,0.0828910040328704,0.0459211417465797,-0.00711443379042592,0.172896441856167,0.0711092430850388
CASQ2,Calsequestrin-2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35152,-0.0766561175090499,0.0444036298512458,-0.163687232017492,0.010374996999392,0.0843320298136533
CASQ2,Calsequestrin-2,Diet and food preferences,X20732.Liking for sweet foods,35152,0.0888348318486357,0.043571761589461,0.00343417913329214,0.174235484563979,0.0415084437616888
CASQ2,Calsequestrin-2,Diet and food preferences,X20733.Liking for taking the stairs,35152,0.0528581524413162,0.0442575111878194,-0.0338865694868098,0.139602874369442,0.232391502522698
CASQ2,Calsequestrin-2,Diet and food preferences,X20734.Liking for tea with sugar,35152,-0.0147223382407375,0.04825543270929,-0.109302986350946,0.0798583098694709,0.760305918296618
CASQ2,Calsequestrin-2,Diet and food preferences,X20735.Liking for tea without sugar,35152,0.0237179259638903,0.0437637642205781,-0.0620590519084428,0.109494903836223,0.58786898251852
CASQ2,Calsequestrin-2,Diet and food preferences,X20736.Liking for tomato ketchup,35152,-0.0230652403900186,0.0444662925774363,-0.110219173841794,0.0640886930617565,0.603978493666376
CASQ2,Calsequestrin-2,Diet and food preferences,X20737.Liking for tinned tuna,35152,0.0684363895482382,0.0447264828613394,-0.019227516859987,0.156100295956463,0.126038117689149
CASQ2,Calsequestrin-2,Diet and food preferences,X20738.Liking for turnip (white),35152,0.0496984722095075,0.0430029092255313,-0.0345872298725338,0.133984174291549,0.247845992215645
CASQ2,Calsequestrin-2,Diet and food preferences,X20739.Liking for vegetables,35152,-0.02459317093521,0.0454069855665494,-0.113590862645647,0.0644045207752268,0.588101189630875
CASQ2,Calsequestrin-2,Diet and food preferences,X20740.Liking for vinegar,35152,-0.0348556019665271,0.0445789510748612,-0.122230346073255,0.052519142140201,0.43431060106459
CASQ2,Calsequestrin-2,Diet and food preferences,X20741.Liking for watching television,35152,-0.063316454938954,0.0433255928836774,-0.148234616990962,0.0216017071130536,0.143950977611
CASQ2,Calsequestrin-2,Diet and food preferences,X20742.Liking for whisky,35152,-0.0111899828344675,0.0430491802225577,-0.0955663760706807,0.0731864104017457,0.794922195919993
CASQ2,Calsequestrin-2,Diet and food preferences,X20743.Liking for white bread,35152,0.0555259357293818,0.0426780281281401,-0.0281229994017729,0.139174870860536,0.193289663164431
CASQ2,Calsequestrin-2,Diet and food preferences,X20744.Liking for white rice,35152,0.0142201479172496,0.044341885491384,-0.0726899476458631,0.101130243480362,0.748453026881431
CASQ2,Calsequestrin-2,Diet and food preferences,X20745.Liking for white wine,35152,-0.027039420149962,0.043977971289797,-0.113236243877964,0.05915740357804,0.538681706728898
CASQ2,Calsequestrin-2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35152,0.0829870681840643,0.0445649366972409,-0.00436020774252797,0.170334344110657,0.0626252538864941
CASQ2,Calsequestrin-2,Diet and food preferences,X20747.Liking for whole milk,35152,0.0788323213918579,0.0446625039325634,-0.00870618631596635,0.166370829099682,0.0775991114589409
CASQ2,Calsequestrin-2,Diet and food preferences,X20748.Liking for wholemeal bread,35152,0.0262341921191364,0.0446397773189784,-0.0612597714260613,0.113728155664334,0.556763055076286
CASQ2,Calsequestrin-2,Diet and food preferences,X20749.Liking for working up a sweat,35152,0.0067274694774206,0.0437442642231862,-0.0790112884000243,0.0924662273548655,0.87777935727576
CASQ2,Calsequestrin-2,Physical measures,X21001.Body mass index (BMI),48326,0.00657364992329047,0.0182911445245882,-0.0292769933449025,0.0424242931914834,0.719307385803085
CASQ2,Calsequestrin-2,Physical measures,X21002.Weight,48351,-0.00625300915737131,0.00886461693606385,-0.0236276583520564,0.0111216400373138,0.480576093565516
CASQ2,Calsequestrin-2,Physical measures,X21021.Pulse wave Arterial Stiffness index,35296,-0.000812833064817051,0.00661244940803044,-0.0137732339045567,0.0121475677749226,0.902170450664789
CASQ2,Calsequestrin-2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34990,0.0724459855021515,0.0489479516800178,-0.0234919997906835,0.168383970794986,0.138906135600507
CASQ2,Calsequestrin-2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34992,-0.00870034926154137,0.0501662529194282,-0.107026204983621,0.0896255064605379,0.862318689011085
CASQ2,Calsequestrin-2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34994,0.0349538819533705,0.0495220443295432,-0.0621093249325341,0.132017088839275,0.480322887784912
CASQ2,Calsequestrin-2,Health and medical history,X21040.Satisfaction with bowel habits,34970,0.030113330274782,0.0454493840120067,-0.0589674623887512,0.119194122938315,0.507630954140453
CASQ2,Calsequestrin-2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34967,0.0140759147351145,0.0494702209150224,-0.0828857182583295,0.111037547728558,0.776011147057529
CASQ2,Calsequestrin-2,Health and medical history,X21042.Greatest number of times bowels opened per day,34965,0.00325504769840635,0.0483175017587224,-0.0914472557486895,0.0979573511455022,0.946290954789257
CASQ2,Calsequestrin-2,Health and medical history,X21043.Least number of times bowels opened per week,34936,0.0063125968027356,0.0481320233790923,-0.0880261690202852,0.100651362625756,0.895659466371135
CASQ2,Calsequestrin-2,Health and medical history,X21044.Average number of times bowels opened per day,34948,-0.0325678088015782,0.0540327771520672,-0.13847205201963,0.0733364344164735,0.54670208383308
CASQ2,Calsequestrin-2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34997,0.0066705478700292,0.0485127122676393,-0.0884143681745437,0.101755463914602,0.890639107329224
CASQ2,Calsequestrin-2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34992,0.0160385459504476,0.0485100135223361,-0.0790410805533312,0.111118172454226,0.740939801414541
CASQ2,Calsequestrin-2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34996,0.154470400810923,0.0613414649269084,0.0342411295541826,0.274699672067663,0.0118196695494853
CASQ2,Calsequestrin-2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34996,-0.0653031142896945,0.0684354413544678,-0.199436579344451,0.0688303507650625,0.340003572224415
CASQ2,Calsequestrin-2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34995,0.0519238885479321,0.0620274228674453,-0.0696498602722606,0.173497637368125,0.40256100574472
CASQ2,Calsequestrin-2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34993,-0.0645757987777714,0.136114537562605,-0.331360292400477,0.202208694844934,0.635214859970168
CASQ2,Calsequestrin-2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34997,0.0571217721866853,0.063773421282552,-0.0678741335271167,0.182117677900487,0.370447398645628
CASQ2,Calsequestrin-2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34995,0.0352123067492572,0.0564276437235729,-0.0753858749489457,0.14581048844746,0.532632889426564
CASQ2,Calsequestrin-2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34876,0.0675668335398755,0.0549219519054938,-0.0400801921948923,0.175213859274643,0.21865574563036
CASQ2,Calsequestrin-2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34994,0.0482058767875188,0.0518550829630151,-0.0534300858199907,0.149841839395028,0.352599426571617
CASQ2,Calsequestrin-2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34996,0.155233171937199,0.0973744492309431,-0.0356207485554491,0.346087092429848,0.110943366249513
CASQ2,Calsequestrin-2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34997,0.0465011250324626,0.0490192189619414,-0.0495765441329426,0.142578794197868,0.342844425424752
CASQ2,Calsequestrin-2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34996,-0.0355148122388864,0.0490052967907489,-0.131565193948754,0.0605355694709815,0.468654174020322
CASQ2,Calsequestrin-2,Working and living environment,X21100.Water hardness (USGS classification),48215,-0.0306332745190347,0.027724437071572,-0.0849731711793158,0.0237066221412465,0.269207973622293
CASQ2,Calsequestrin-2,Lifestyle factors,X2139.Age first had sexual intercourse,45851,-0.00373385441076556,0.00363094561317015,-0.010850507812579,0.00338279899104793,0.303803329424593
CASQ2,Calsequestrin-2,Health and medical history,X2149.Lifetime number of sexual partners,44432,0.0202253219404159,0.0313805321082675,-0.0412805209917885,0.0817311648726202,0.519248842087559
CASQ2,Calsequestrin-2,Physical activities,X22032.IPAQ activity group,45184,-0.00981737138430899,0.0299031734486008,-0.0684275913435666,0.0487928485749487,0.74268495575709
CASQ2,Calsequestrin-2,Physical activities,X22033.Summed days activity,45506,0.000137708720348083,0.00361118604528205,-0.00694021592840474,0.00721563336910091,0.969581348018207
CASQ2,Calsequestrin-2,Physical activities,X22034.Summed minutes activity,45184,0.000270667058988408,0.00365111594693029,-0.00688552019699497,0.00742685431497178,0.940905695364136
CASQ2,Calsequestrin-2,Physical activities,X22037.MET minutes per week for walking,44590,-0.00200414910415835,0.00372063411466294,-0.00929659196889771,0.00528829376058102,0.590130399677263
CASQ2,Calsequestrin-2,Physical activities,X22038.MET minutes per week for moderate activity,45184,0.00104245823295128,0.00370995531322063,-0.00622905418096115,0.00831397064686372,0.778722011530892
CASQ2,Calsequestrin-2,Physical activities,X22039.MET minutes per week for vigorous activity,45184,0.012068596482642,0.0299262263380364,-0.0465868071399092,0.0707240001051933,0.686748732374378
CASQ2,Calsequestrin-2,Physical activities,X22040.Summed MET minutes per week for all activity,44590,0.00104570176082109,0.00368451184947149,-0.00617594146414303,0.0082673449857852,0.776559571029275
CASQ2,Calsequestrin-2,Eye measures,X2217.Age started wearing glasses or contact lenses,45215,-9.7896589316896e-05,0.00376953947615039,-0.00748619396257167,0.00729040078393788,0.979281229853666
CASQ2,Calsequestrin-2,Working and living environment,X22501.Year ended full time education,33164,-0.00387221224036962,0.0173463735995348,-0.0378711044954578,0.0301266800147186,0.823367335187328
CASQ2,Calsequestrin-2,Lifestyle factors,X22506.Tobacco smoking,33132,0.0258687350988491,0.117048522963039,-0.203546369908707,0.255283840106405,0.82509566462832
CASQ2,Calsequestrin-2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47205,-0.193320164025244,0.0979013870539752,-0.385206882651035,-0.00143344539945245,0.0483235839026476
CASQ2,Calsequestrin-2,Physical measures,X23098.Weight,47982,-0.00691902653495146,0.00894515085988921,-0.0244515222203343,0.0106134691504314,0.439239113943405
CASQ2,Calsequestrin-2,Physical measures,X23099.Body fat percentage,47952,0.00530828702512079,0.00801535216163491,-0.0104018032116836,0.0210183772619252,0.5078093038021
CASQ2,Calsequestrin-2,Physical measures,X23100.Whole body fat mass,47914,-0.000621165064867663,0.00801894219088737,-0.0163382917590069,0.0150959616292716,0.938256647335398
CASQ2,Calsequestrin-2,Physical measures,X23101.Whole body fat-free mass,47977,-0.00884669335819726,0.00774024211908774,-0.0240175679116092,0.00632418119521472,0.253074350593944
CASQ2,Calsequestrin-2,Physical measures,X23102.Whole body water mass,47982,-0.00748443721965946,0.00771650618373806,-0.0226087893397861,0.00763991490046713,0.332095660526705
CASQ2,Calsequestrin-2,Physical measures,X23104.Body mass index (BMI),47982,-0.0010600803866426,0.0180654731419084,-0.036468407744783,0.0343482469714978,0.953207664057359
CASQ2,Calsequestrin-2,Physical measures,X23105.Basal metabolic rate,47982,-0.00881321763019232,0.00803498687164403,-0.0245617918986146,0.00693535663822997,0.27271829555911
CASQ2,Calsequestrin-2,Physical measures,X23106.Impedance of whole body,47982,0.00578738208773092,0.00633558033161728,-0.00663035536223895,0.0182051195377008,0.361005147417443
CASQ2,Calsequestrin-2,Physical measures,X23107.Impedance of leg (right),47982,0.00571788713689369,0.00513268781894883,-0.00434218098824601,0.0157779552620334,0.265286907236218
CASQ2,Calsequestrin-2,Physical measures,X23108.Impedance of leg (left),47982,0.00421008002956799,0.00510377599745767,-0.00579332092544904,0.014213480984585,0.409441276052515
CASQ2,Calsequestrin-2,Physical measures,X23109.Impedance of arm (right),47982,0.00539795220094869,0.00627967060788528,-0.00691020219050646,0.0177061065924038,0.390024830086738
CASQ2,Calsequestrin-2,Physical measures,X23110.Impedance of arm (left),47982,0.00357334774115467,0.00627290064242546,-0.00872153751799924,0.0158682330003086,0.568922804065165
CASQ2,Calsequestrin-2,Physical measures,X23111.Leg fat percentage (right),47982,0.00595998061290882,0.00813479034315597,-0.00998420845967687,0.0219041696854945,0.463778801877355
CASQ2,Calsequestrin-2,Physical measures,X23112.Leg fat mass (right),47982,0.00236553451506644,0.00876399632303599,-0.0148118982780841,0.019542967308217,0.787228481319521
CASQ2,Calsequestrin-2,Physical measures,X23113.Leg fat-free mass (right),47981,-0.0172938919096489,0.00850054394051833,-0.0339549580330649,-0.000632825786233009,0.0419203009692209
CASQ2,Calsequestrin-2,Physical measures,X23114.Leg predicted mass (right),47981,-0.0175686851568545,0.00856459118221575,-0.0343552838739974,-0.000782086439711661,0.0402495695231468
CASQ2,Calsequestrin-2,Physical measures,X23115.Leg fat percentage (left),47981,0.00353973461308228,0.00850196248848558,-0.0131241118643495,0.020203581090514,0.677163466039883
CASQ2,Calsequestrin-2,Physical measures,X23116.Leg fat mass (left),47981,-0.00282408710895912,0.00927863630882496,-0.021010214274256,0.0153620400563378,0.760853510457578
CASQ2,Calsequestrin-2,Physical measures,X23117.Leg fat-free mass (left),47980,-0.0161544832516236,0.0092382969004147,-0.0342615451764364,0.00195257867318921,0.080368579536876
CASQ2,Calsequestrin-2,Physical measures,X23118.Leg predicted mass (left),47980,-0.0161682066379661,0.00931289963315421,-0.0344214899189484,0.00208507664301614,0.0825604981278956
CASQ2,Calsequestrin-2,Physical measures,X23119.Arm fat percentage (right),47980,0.0145495880259993,0.00899492128713595,-0.00308045769678712,0.0321796337487858,0.105779408690783
CASQ2,Calsequestrin-2,Physical measures,X23120.Arm fat mass (right),47979,0.00773784649071219,0.00982425245825893,-0.0115176883274753,0.0269933813088997,0.430924549903616
CASQ2,Calsequestrin-2,Physical measures,X23121.Arm fat-free mass (right),47978,-0.0102665062488644,0.00847327270212413,-0.0268741207450277,0.00634110824729892,0.225667244902418
CASQ2,Calsequestrin-2,Physical measures,X23122.Arm predicted mass (right),47978,-0.0113761192447366,0.00851756428580773,-0.0280705452449198,0.00531830675544652,0.181693418423959
CASQ2,Calsequestrin-2,Physical measures,X23123.Arm fat percentage (left),47976,0.0111174595942003,0.00847147834535762,-0.00548663796270063,0.0277215571511012,0.189420998827055
CASQ2,Calsequestrin-2,Physical measures,X23124.Arm fat mass (left),47976,0.00306148066004285,0.00941260036072854,-0.0153872160469851,0.0215101773670708,0.744992776921128
CASQ2,Calsequestrin-2,Physical measures,X23125.Arm fat-free mass (left),47972,-0.00657702094659987,0.00771628708352436,-0.0217009436303076,0.00854690173710787,0.394027261024728
CASQ2,Calsequestrin-2,Physical measures,X23126.Arm predicted mass (left),47971,-0.00478684829578764,0.00775587389125378,-0.0199883611226451,0.0104146645310698,0.53711662358611
CASQ2,Calsequestrin-2,Physical measures,X23127.Trunk fat percentage,47970,0.0018429266812275,0.00677394572747921,-0.0114340069446317,0.0151198603070867,0.785577989604615
CASQ2,Calsequestrin-2,Physical measures,X23128.Trunk fat mass,47970,8.62779410314573e-05,0.00713419908690454,-0.0138967522693014,0.0140693081513643,0.990351086405279
CASQ2,Calsequestrin-2,Physical measures,X23129.Trunk fat-free mass,47969,-0.00338408990776323,0.00670705120106736,-0.0165299102618553,0.00976173044632879,0.613875728914144
CASQ2,Calsequestrin-2,Physical measures,X23130.Trunk predicted mass,47967,-0.00300611358456997,0.0067088427947195,-0.0161554454622202,0.0101432182930802,0.654098827414074
CASQ2,Calsequestrin-2,NMR metabolomics,X23400.Total Cholesterol,39575,0.0049107129406465,0.00484436369681924,-0.00458423990511921,0.0144056657864122,0.310750097493303
CASQ2,Calsequestrin-2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39575,0.00505092903925621,0.00472545971599275,-0.00421097200408958,0.014312830082602,0.285149193420377
CASQ2,Calsequestrin-2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39575,0.00618241094747856,0.00474834996418909,-0.00312435498233206,0.0154891768772892,0.192939441964129
CASQ2,Calsequestrin-2,NMR metabolomics,X23403.VLDL Cholesterol,39575,0.00594549919751895,0.00487958103766164,-0.00361847963629786,0.0155094780313358,0.223081253700402
CASQ2,Calsequestrin-2,NMR metabolomics,X23404.Clinical LDL Cholesterol,39575,0.00445481652510215,0.00471342461962047,-0.00478349572935397,0.0136931287795583,0.344611420835723
CASQ2,Calsequestrin-2,NMR metabolomics,X23405.LDL Cholesterol,39575,0.00412827108488277,0.00469170502162603,-0.00506747075750424,0.0133240129272698,0.378928150670976
CASQ2,Calsequestrin-2,NMR metabolomics,X23406.HDL Cholesterol,39575,-7.79314444658779e-05,0.00536244890455807,-0.0105883312973997,0.0104324684084679,0.98840516857081
CASQ2,Calsequestrin-2,NMR metabolomics,X23407.Total Triglycerides,39575,0.00546315740763606,0.00494403804659187,-0.004227157163684,0.0151534719789561,0.269184218829559
CASQ2,Calsequestrin-2,NMR metabolomics,X23408.Triglycerides in VLDL,39575,0.0048635378150937,0.0050129265262221,-0.00496179817630162,0.014688873806489,0.331968539292532
CASQ2,Calsequestrin-2,NMR metabolomics,X23409.Triglycerides in LDL,39575,0.00513930832734769,0.00468246680785088,-0.00403832661604003,0.0143169432707354,0.272418875611385
CASQ2,Calsequestrin-2,NMR metabolomics,X23410.Triglycerides in HDL,39575,0.00272723262535141,0.00484395108473807,-0.00676691150073521,0.012221376751438,0.573433991292391
CASQ2,Calsequestrin-2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39575,0.00405804885132852,0.00486706799296398,-0.00548140441488089,0.0135975021175379,0.404424861921518
CASQ2,Calsequestrin-2,NMR metabolomics,X23412.Phospholipids in VLDL,39575,0.00562050401516387,0.00492222716245526,-0.00402706122324844,0.0152680692535762,0.253536309490627
CASQ2,Calsequestrin-2,NMR metabolomics,X23413.Phospholipids in LDL,39575,0.00409900852765217,0.00471032338938764,-0.0051332253155476,0.0133312423708519,0.384200275278974
CASQ2,Calsequestrin-2,NMR metabolomics,X23414.Phospholipids in HDL,39575,-0.000652097906973195,0.00511713889804018,-0.010681690147132,0.00937749433318556,0.898599175864613
CASQ2,Calsequestrin-2,NMR metabolomics,X23415.Total Esterified Cholesterol,39575,0.00474003913877265,0.00487186687037176,-0.00480881992715599,0.0142888982047013,0.330604057187408
CASQ2,Calsequestrin-2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39575,0.00575007613644107,0.00485685355952273,-0.00376935684022349,0.0152695091131056,0.236474442843766
CASQ2,Calsequestrin-2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39575,0.00401101723427686,0.00469049354514833,-0.00518235011421388,0.0132043845827676,0.392493661891145
CASQ2,Calsequestrin-2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39575,-0.000457166892161471,0.00536470965457977,-0.0109719978151378,0.0100576640308149,0.93209007007338
CASQ2,Calsequestrin-2,NMR metabolomics,X23419.Total Free Cholesterol,39575,0.0053557466632005,0.00478087221729824,-0.00401476288270406,0.0147262562091051,0.262634022745378
CASQ2,Calsequestrin-2,NMR metabolomics,X23420.Free Cholesterol in VLDL,39575,0.00594368858090225,0.00490609454414344,-0.0036722567256189,0.0155596338874234,0.225733428451638
CASQ2,Calsequestrin-2,NMR metabolomics,X23421.Free Cholesterol in LDL,39575,0.00434862959693174,0.00471538400521165,-0.0048935230532831,0.0135907822471466,0.356433202950542
CASQ2,Calsequestrin-2,NMR metabolomics,X23422.Free Cholesterol in HDL,39575,0.00151605894577334,0.00532486345273435,-0.00892067342158598,0.0119527913131327,0.775869244077536
CASQ2,Calsequestrin-2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39575,0.00504744892747144,0.00467284068721945,-0.00411131881947869,0.0142062166744216,0.280091497496095
CASQ2,Calsequestrin-2,NMR metabolomics,X23424.Total Lipids in VLDL,39575,0.0056578793981366,0.0049210285230787,-0.00398733650709765,0.0153030953033709,0.250278031097604
CASQ2,Calsequestrin-2,NMR metabolomics,X23425.Total Lipids in LDL,39575,0.00416955442297359,0.0046943385440812,-0.00503134912342556,0.0133704579693728,0.374447725963742
CASQ2,Calsequestrin-2,NMR metabolomics,X23426.Total Lipids in HDL,39575,-0.00027260584990887,0.00520809523098956,-0.0104804725026484,0.00993526080283066,0.95825657007071
CASQ2,Calsequestrin-2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39575,0.00038981248026049,0.00495829637465293,-0.00932844841405924,0.0101080733745802,0.937337720972172
CASQ2,Calsequestrin-2,NMR metabolomics,X23428.Concentration of VLDL Particles,39575,0.00539365040037491,0.00486339470164241,-0.00413860321484422,0.014925904015594,0.26744156132004
CASQ2,Calsequestrin-2,NMR metabolomics,X23429.Concentration of LDL Particles,39575,0.00465783011400236,0.00470852657600944,-0.00457088197497615,0.0138865422029809,0.322570939153054
CASQ2,Calsequestrin-2,NMR metabolomics,X23430.Concentration of HDL Particles,39575,-0.000548590427593883,0.00495837460283552,-0.0102670046491515,0.00916982379396374,0.911904511706949
CASQ2,Calsequestrin-2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39575,0.00416507497959157,0.00508958990159086,-0.00581052122752652,0.0141406711867097,0.413174111857481
CASQ2,Calsequestrin-2,NMR metabolomics,X23432.Average Diameter for LDL Particles,39575,-0.000447897316659832,0.00483955013327965,-0.00993341557788794,0.00903762094456828,0.92626325701876
CASQ2,Calsequestrin-2,NMR metabolomics,X23433.Average Diameter for HDL Particles,39575,0.001207439234127,0.00533356384496962,-0.00924634590201346,0.0116612243702675,0.820906153478338
CASQ2,Calsequestrin-2,NMR metabolomics,X23434.Phosphoglycerides,39565,0.00320985396644239,0.00487641807447494,-0.0063479254595285,0.0127676333924133,0.510397674900875
CASQ2,Calsequestrin-2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39565,0.00379495505663753,0.00521393033788003,-0.00642434840560731,0.0140142585188824,0.466721440891904
CASQ2,Calsequestrin-2,NMR metabolomics,X23436.Total Cholines,39565,0.00317161955439619,0.0049639237911631,-0.00655767107628348,0.0129009101850759,0.522879231314892
CASQ2,Calsequestrin-2,NMR metabolomics,X23437.Phosphatidylcholines,39565,0.00292481498581376,0.00497792409941887,-0.00683191624904723,0.0126815462206747,0.556841666668162
CASQ2,Calsequestrin-2,NMR metabolomics,X23438.Sphingomyelins,39565,0.00494905896127538,0.0050197513558593,-0.00488965369620885,0.0147877716187596,0.324195523439903
CASQ2,Calsequestrin-2,NMR metabolomics,X23439.Apolipoprotein B,39575,0.0050147882890598,0.00472775875905839,-0.00425161887869465,0.0142811954568142,0.288844354012386
CASQ2,Calsequestrin-2,NMR metabolomics,X23440.Apolipoprotein A1,39575,-0.000551950366627863,0.00509925103743673,-0.0105464824000039,0.00944258166674813,0.913806138149506
CASQ2,Calsequestrin-2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39575,0.00513913798300223,0.00481032452783367,-0.00428909809155175,0.0145673740575562,0.285383556501651
CASQ2,Calsequestrin-2,NMR metabolomics,X23442.Total Fatty Acids,39565,0.00464578404035645,0.00454504117115312,-0.00426249665510367,0.0135540647358166,0.306725152140134
CASQ2,Calsequestrin-2,NMR metabolomics,X23443.Degree of Unsaturation,39565,-0.00414432254510187,0.00489399989366309,-0.0137365623366815,0.00544791724647779,0.39711558538349
CASQ2,Calsequestrin-2,NMR metabolomics,X23444.Omega-3 Fatty Acids,39565,0.00391707203406485,0.00477829963823962,-0.00544839525688481,0.0132825393250145,0.412369190436002
CASQ2,Calsequestrin-2,NMR metabolomics,X23445.Omega-6 Fatty Acids,39565,0.000878424384136953,0.00470847436563126,-0.00835018537250032,0.0101070341407742,0.852007183220283
CASQ2,Calsequestrin-2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39565,0.00208155675986982,0.00473054834791887,-0.00719031800205117,0.0113534315217908,0.659928098738433
CASQ2,Calsequestrin-2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39565,0.00419615471942064,0.00462199438328347,-0.00486295427181497,0.0132552637106562,0.363968612837382
CASQ2,Calsequestrin-2,NMR metabolomics,X23448.Saturated Fatty Acids,39565,0.00645960006516716,0.00448282492425303,-0.00232673678636878,0.0152459369167031,0.149622731777054
CASQ2,Calsequestrin-2,NMR metabolomics,X23449.Linoleic Acid,39565,0.00115033829827106,0.00469923292620068,-0.00806015823708227,0.0103608348336244,0.806621464194338
CASQ2,Calsequestrin-2,NMR metabolomics,X23450.Docosahexaenoic Acid,39565,0.00485258124104053,0.00474272726737348,-0.0044431642030115,0.0141483266850926,0.306253537047457
CASQ2,Calsequestrin-2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39565,0.00230196657390954,0.00479172758507278,-0.00708981949283311,0.0116937526406522,0.630949515614287
CASQ2,Calsequestrin-2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39565,-0.0080859116566051,0.00467367665515394,-0.0172463179007068,0.00107449458749661,0.0836411722393722
CASQ2,Calsequestrin-2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39565,-0.0066238462836784,0.00478633439412363,-0.0160050616961607,0.00275736912880391,0.166414806109309
CASQ2,Calsequestrin-2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39565,0.0019387644702251,0.00504614599985569,-0.00795168168949204,0.0118292106299422,0.700832502223651
CASQ2,Calsequestrin-2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39565,0.00787906480623935,0.00437005335576899,-0.000686239771067866,0.0164443693835466,0.0714207399778602
CASQ2,Calsequestrin-2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39565,-0.00485017471233368,0.00478222244747526,-0.0142233307093852,0.00452298128471784,0.310505247145573
CASQ2,Calsequestrin-2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39565,0.00238010429260596,0.00468333323305697,-0.00679922884418569,0.0115594374293976,0.61131817215515
CASQ2,Calsequestrin-2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39565,-0.00463481784077913,0.00498434017225989,-0.0144041245784085,0.00513448889685025,0.352455808978973
CASQ2,Calsequestrin-2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39565,-0.00394504321800243,0.00472924315849484,-0.0132143598086523,0.00532427337264746,0.404197355349427
CASQ2,Calsequestrin-2,NMR metabolomics,X23460.Alanine,39572,-0.00746279502957886,0.00472064451198328,-0.0167152582730661,0.00178966821390837,0.113933211065398
CASQ2,Calsequestrin-2,NMR metabolomics,X23461.Glutamine,39542,0.00092417427812024,0.00462389014383428,-0.00813865040379495,0.00998699896003543,0.841586415087321
CASQ2,Calsequestrin-2,NMR metabolomics,X23462.Glycine,39562,-0.00357941847174222,0.00563062200560562,-0.0146154376027292,0.0074566006592448,0.524981534798182
CASQ2,Calsequestrin-2,NMR metabolomics,X23463.Histidine,39560,-0.00280881884061758,0.00465492626228024,-0.0119324743146868,0.00631483663345168,0.54624991787664
CASQ2,Calsequestrin-2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39566,-0.00501902330345061,0.00522723707089333,-0.0152644079624015,0.00522636135550032,0.336992075686619
CASQ2,Calsequestrin-2,NMR metabolomics,X23465.Isoleucine,39573,-0.000221211690234694,0.00504784739022566,-0.010114992575077,0.00967256919460759,0.965046310617817
CASQ2,Calsequestrin-2,NMR metabolomics,X23466.Leucine,39573,-0.00309319906675157,0.00516753064150922,-0.0132215591241096,0.00703516099060651,0.549462954270802
CASQ2,Calsequestrin-2,NMR metabolomics,X23467.Valine,39566,-0.00705306569889356,0.00520356742860462,-0.0172520578589586,0.00314592646117149,0.175308861291716
CASQ2,Calsequestrin-2,NMR metabolomics,X23468.Phenylalanine,39569,0.00155208771985947,0.00477249087472081,-0.00780199439459332,0.0109061698343123,0.745024226462103
CASQ2,Calsequestrin-2,NMR metabolomics,X23469.Tyrosine,39562,0.0015537729266761,0.00498485664150814,-0.00821654609067985,0.0113240919440321,0.755275506023743
CASQ2,Calsequestrin-2,NMR metabolomics,X23470.Glucose,39556,-0.00369330487969392,0.0045479252743914,-0.0126072384175011,0.00522062865811322,0.41676012696004
CASQ2,Calsequestrin-2,NMR metabolomics,X23471.Lactate,39558,0.00714492888356516,0.0047905853364629,-0.00224461837590214,0.0165344761430324,0.135871606026928
CASQ2,Calsequestrin-2,NMR metabolomics,X23472.Pyruvate,39539,0.00052661317034333,0.00457483592534198,-0.00844006524332695,0.00949329158401361,0.908359386935467
CASQ2,Calsequestrin-2,NMR metabolomics,X23473.Citrate,39573,0.00366698995838733,0.00474696744792859,-0.0056370662395527,0.0129710461563274,0.439840272210476
CASQ2,Calsequestrin-2,NMR metabolomics,X23474.3-Hydroxybutyrate,39353,0.00545326625006144,0.00524738725647828,-0.00483161277263599,0.0157381452727589,0.298719022158221
CASQ2,Calsequestrin-2,NMR metabolomics,X23475.Acetate,39563,0.0062413128140157,0.00449882205482475,-0.00257637841344081,0.0150590040414722,0.165371933481125
CASQ2,Calsequestrin-2,NMR metabolomics,X23476.Acetoacetate,39574,-0.0015712220817329,0.00478354825009739,-0.0109469766519238,0.00780453248845798,0.742567333755954
CASQ2,Calsequestrin-2,NMR metabolomics,X23477.Acetone,39574,0.00174640320185603,0.00473358856339371,-0.00753143038239563,0.0110242367861077,0.712180661519563
CASQ2,Calsequestrin-2,NMR metabolomics,X23478.Creatinine,39370,0.00161844820470079,0.00586507193047437,-0.00987709277902898,0.0131139891884306,0.782594173164563
CASQ2,Calsequestrin-2,NMR metabolomics,X23479.Albumin,39573,0.00370854175704683,0.00471617184703283,-0.00553515506313752,0.0129522385772312,0.431681928871325
CASQ2,Calsequestrin-2,NMR metabolomics,X23480.Glycoprotein Acetyls,39575,-0.00302636743816532,0.00492190415286162,-0.0126732995777741,0.00662056470144346,0.538648462234551
CASQ2,Calsequestrin-2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39575,0.00583732891871007,0.00497215451674597,-0.00390809393411203,0.0155827517715322,0.240418928074214
CASQ2,Calsequestrin-2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39575,0.00565261926553109,0.00494119150384089,-0.00403211608199705,0.0153373546130592,0.252657300324551
CASQ2,Calsequestrin-2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39575,0.00480195050472668,0.00511141871193571,-0.0052164301706673,0.0148203311801207,0.347517596075944
CASQ2,Calsequestrin-2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39575,0.00592309099852538,0.00502699834993953,-0.00392982576735609,0.0157760077644068,0.238720107217352
CASQ2,Calsequestrin-2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39575,0.00606182637859146,0.0050224038231641,-0.00378208511481017,0.0159057378719931,0.227474646081871
CASQ2,Calsequestrin-2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39575,0.00564130994690541,0.00499444937302588,-0.00414781082422531,0.0154304307180361,0.258704954933973
CASQ2,Calsequestrin-2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39575,0.00555351843563652,0.00484900240981466,-0.00395052628760022,0.0150575631588733,0.252113639200159
CASQ2,Calsequestrin-2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39575,0.00498330899521173,0.00517148827545852,-0.00515280802468696,0.0151194260151104,0.335261638120745
CASQ2,Calsequestrin-2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39575,0.00487176191687091,0.00513582735848332,-0.0051944597057564,0.0149379835394982,0.342853290621634
CASQ2,Calsequestrin-2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39575,0.00577317597390979,0.00513356916232955,-0.00428861958425613,0.0158349715320757,0.260786133839896
CASQ2,Calsequestrin-2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39575,0.00525591766885058,0.00510910882746359,-0.00475793563297804,0.0152697709706792,0.303627018141164
CASQ2,Calsequestrin-2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39575,0.00469325351337111,0.00510826306081414,-0.00531894208582459,0.0147054491125668,0.358242769926026
CASQ2,Calsequestrin-2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39575,0.00594982969255169,0.00509375151242578,-0.00403392327180284,0.0159335826569062,0.242806171082823
CASQ2,Calsequestrin-2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39575,0.00433246672697437,0.00514827495093764,-0.00575815217686341,0.0144230856308122,0.400065189529821
CASQ2,Calsequestrin-2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39575,0.00470736426689172,0.0050956416520378,-0.00528009337110238,0.0146948219048858,0.355609690852202
CASQ2,Calsequestrin-2,NMR metabolomics,X23496.Total Lipids in Large VLDL,39575,0.00447285790270414,0.00507889623675296,-0.00548177872133166,0.0144274945267399,0.378512934000393
CASQ2,Calsequestrin-2,NMR metabolomics,X23497.Phospholipids in Large VLDL,39575,0.00417706276343497,0.00518174677456228,-0.0059791609147071,0.014333286441577,0.420196350051038
CASQ2,Calsequestrin-2,NMR metabolomics,X23498.Cholesterol in Large VLDL,39575,0.00469117087838721,0.00512512664894822,-0.00535407735355129,0.0147364191103257,0.360039681406698
CASQ2,Calsequestrin-2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39575,0.00466374570735132,0.00509054442489878,-0.0053137213654503,0.0146412127801529,0.35960388146688
CASQ2,Calsequestrin-2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39575,0.00456594859574191,0.00516838787571961,-0.00556409164066854,0.0146959888321523,0.377019190607579
CASQ2,Calsequestrin-2,NMR metabolomics,X23501.Triglycerides in Large VLDL,39575,0.00413697879427215,0.00500070220923773,-0.00566439753583379,0.0139383551243781,0.408096604856334
CASQ2,Calsequestrin-2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39575,0.00498011674611001,0.00482195744992634,-0.00447091985574562,0.0144311533479656,0.301720349603549
CASQ2,Calsequestrin-2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39575,0.00456726061255554,0.00483119587380272,-0.00490188330009779,0.0140364045252089,0.344491567280657
CASQ2,Calsequestrin-2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39575,0.00487782363750439,0.00481221561218368,-0.00455411896237562,0.0143097662373844,0.310779943995868
CASQ2,Calsequestrin-2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39575,0.00475084832599603,0.00473544885740921,-0.00453063143452602,0.0140323280865181,0.315761429253261
CASQ2,Calsequestrin-2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39575,0.00435043996743751,0.00472082177104701,-0.00490237070381463,0.0136032506386897,0.356787290641951
CASQ2,Calsequestrin-2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39575,0.00515989403272861,0.00478995854785459,-0.00422842472106639,0.0145482127865236,0.281400551658938
CASQ2,Calsequestrin-2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39575,0.00349840825288838,0.00494936211385229,-0.00620234149026211,0.0131991579960389,0.479680777628715
CASQ2,Calsequestrin-2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39575,0.00354072562342123,0.00496808930506016,-0.00619672941449669,0.0132781806613392,0.476050507824247
CASQ2,Calsequestrin-2,NMR metabolomics,X23510.Total Lipids in Small VLDL,39575,0.00347592973237237,0.00497545257941546,-0.00627595732328194,0.0132278167880267,0.484806976277356
CASQ2,Calsequestrin-2,NMR metabolomics,X23511.Phospholipids in Small VLDL,39575,0.00379752077171914,0.00488585651046419,-0.00577875798879066,0.0133737995322289,0.43702939290318
CASQ2,Calsequestrin-2,NMR metabolomics,X23512.Cholesterol in Small VLDL,39575,0.0040940780830721,0.0049307325888712,-0.00557015779111545,0.0137583139572596,0.406376838479469
CASQ2,Calsequestrin-2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39575,0.00411597971275216,0.00501605922742406,-0.005715496372999,0.0139474557985033,0.411914516780262
CASQ2,Calsequestrin-2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39575,0.00389378577241969,0.00479841050869057,-0.00551109882461383,0.0132986703694532,0.417111067906864
CASQ2,Calsequestrin-2,NMR metabolomics,X23515.Triglycerides in Small VLDL,39575,0.00205284178733415,0.00501319563468805,-0.00777302165665443,0.0118787052313227,0.6821898067196
CASQ2,Calsequestrin-2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39575,0.00565752972564022,0.00477091429818114,-0.00369346229879482,0.0150085217500753,0.235712098531857
CASQ2,Calsequestrin-2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39575,0.00560325150033979,0.0047992386479926,-0.0038032562497257,0.0150097592504053,0.243022067154867
CASQ2,Calsequestrin-2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39575,0.00537942644721504,0.00477950922179177,-0.00398841162749683,0.0147472645219269,0.260393959195231
CASQ2,Calsequestrin-2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39575,0.00592832758219301,0.00483679998521003,-0.00355180038881865,0.0154084555532047,0.220348643739045
CASQ2,Calsequestrin-2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39575,0.00587482896105997,0.00487157087376921,-0.00367344995152767,0.0154231078736476,0.22786608612331
CASQ2,Calsequestrin-2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39575,0.00587629854916336,0.00479076128774902,-0.00351359357482472,0.0152661906731514,0.220003148663355
CASQ2,Calsequestrin-2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39575,0.00286506891890659,0.00487159450833346,-0.006683256317427,0.0124133941552402,0.556465675545513
CASQ2,Calsequestrin-2,NMR metabolomics,X23523.Concentration of IDL Particles,39575,0.00559281025481899,0.00474109704030973,-0.00369973994418807,0.0148853604538261,0.238167104528868
CASQ2,Calsequestrin-2,NMR metabolomics,X23524.Total Lipids in IDL,39575,0.00565530230963535,0.00485006032447057,-0.00385081592632697,0.0151614205455977,0.243628782563641
CASQ2,Calsequestrin-2,NMR metabolomics,X23525.Phospholipids in IDL,39575,0.0052568795180576,0.00484339139718134,-0.00423616762041783,0.014749926656533,0.27778094094835
CASQ2,Calsequestrin-2,NMR metabolomics,X23526.Cholesterol in IDL,39575,0.00560934540010769,0.00487373768138816,-0.00394318045541311,0.0151618712556285,0.249784885656495
CASQ2,Calsequestrin-2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39575,0.00548288948786569,0.00488104048202203,-0.00408394985689749,0.0150497288326289,0.261333220790947
CASQ2,Calsequestrin-2,NMR metabolomics,X23528.Free Cholesterol in IDL,39575,0.00597300489832608,0.00483414877678304,-0.00350192670416868,0.0154479365008208,0.21663906524199
CASQ2,Calsequestrin-2,NMR metabolomics,X23529.Triglycerides in IDL,39575,0.00425124666429424,0.00471674678084629,-0.00499357702616448,0.013496070354753,0.367443789590595
CASQ2,Calsequestrin-2,NMR metabolomics,X23530.Concentration of Large LDL Particles,39575,0.00434399031751519,0.00468945755462212,-0.00484734648954416,0.0135353271245745,0.354294313648765
CASQ2,Calsequestrin-2,NMR metabolomics,X23531.Total Lipids in Large LDL,39575,0.00425904575542852,0.00471954607953085,-0.00499126456045194,0.013509356071309,0.366849894462462
CASQ2,Calsequestrin-2,NMR metabolomics,X23532.Phospholipids in Large LDL,39575,0.00425311132638784,0.00473362241516445,-0.00502478860733447,0.0135310112601102,0.368944206311596
CASQ2,Calsequestrin-2,NMR metabolomics,X23533.Cholesterol in Large LDL,39575,0.00421789194656408,0.00472040569020771,-0.00503410320624303,0.0134698870993712,0.37158531303461
CASQ2,Calsequestrin-2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39575,0.00398288546364851,0.00471290787812575,-0.00525441397747795,0.013220184904775,0.398072599830295
CASQ2,Calsequestrin-2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39575,0.00474942951232349,0.00475934227131894,-0.00457888133946163,0.0140777403641086,0.318341511865559
CASQ2,Calsequestrin-2,NMR metabolomics,X23536.Triglycerides in Large LDL,39575,0.0048731522631611,0.00467710728721602,-0.0042939780197823,0.0140402825461045,0.297473640730974
CASQ2,Calsequestrin-2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39575,0.00464732960401321,0.00473252318875617,-0.00462841584594889,0.0139230750539753,0.326122345006685
CASQ2,Calsequestrin-2,NMR metabolomics,X23538.Total Lipids in Medium LDL,39575,0.00375739953645361,0.00471148852600876,-0.00547711797452357,0.0129919170474308,0.425179504221812
CASQ2,Calsequestrin-2,NMR metabolomics,X23539.Phospholipids in Medium LDL,39575,0.00341288427740032,0.00473094456002351,-0.00585976706024575,0.0126855356150464,0.470681300785978
CASQ2,Calsequestrin-2,NMR metabolomics,X23540.Cholesterol in Medium LDL,39575,0.00376240183995994,0.00470252583241555,-0.00545454879157455,0.0129793524714944,0.423681152634811
CASQ2,Calsequestrin-2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39575,0.00393888098539621,0.00471878197899971,-0.00530993169344321,0.0131876936642356,0.403891244703334
CASQ2,Calsequestrin-2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39575,0.00337538295185425,0.00468111393537492,-0.00579960036148059,0.0125503662651891,0.470885470096484
CASQ2,Calsequestrin-2,NMR metabolomics,X23543.Triglycerides in Medium LDL,39575,0.00509957585426593,0.0047069972431662,-0.00412613874233983,0.0143252904508717,0.278653298556163
CASQ2,Calsequestrin-2,NMR metabolomics,X23544.Concentration of Small LDL Particles,39575,0.00511939822355303,0.00474012866424173,-0.00417125395836076,0.0144100504054668,0.280160345454458
CASQ2,Calsequestrin-2,NMR metabolomics,X23545.Total Lipids in Small LDL,39575,0.00435142095183186,0.00467837584518647,-0.00481819570473362,0.0135210376083973,0.352332732610843
CASQ2,Calsequestrin-2,NMR metabolomics,X23546.Phospholipids in Small LDL,39575,0.00446059240981283,0.00466700941536268,-0.00468674604429802,0.0136079308639237,0.339208977654714
CASQ2,Calsequestrin-2,NMR metabolomics,X23547.Cholesterol in Small LDL,39575,0.0041185817170424,0.0046891438503877,-0.00507214022971749,0.0133093036638023,0.379787821629237
CASQ2,Calsequestrin-2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39575,0.00422791391095002,0.00469232353181167,-0.00496904021140084,0.0134248680333009,0.367593314460666
CASQ2,Calsequestrin-2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39575,0.00390606872286697,0.00468507373344797,-0.00527667579469105,0.013088813240425,0.404453434915224
CASQ2,Calsequestrin-2,NMR metabolomics,X23550.Triglycerides in Small LDL,39575,0.00587807834500048,0.00475217119482095,-0.00343617719684858,0.0151923338868495,0.216141473057428
CASQ2,Calsequestrin-2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39575,0.00595417177953056,0.00542714112030447,-0.0046830248162662,0.0165913683753273,0.272617300683116
CASQ2,Calsequestrin-2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39575,0.00495923537115887,0.00544358006455436,-0.00571018155536768,0.0156286522976854,0.362302418711113
CASQ2,Calsequestrin-2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39575,0.00446921271895613,0.00541055990942816,-0.00613548470352306,0.0150739101414353,0.408812587001904
CASQ2,Calsequestrin-2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39575,0.00548627021704894,0.00551536867084945,-0.00532385237781598,0.0162963928119139,0.31989239309482
CASQ2,Calsequestrin-2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39575,0.00482201697711941,0.00554598630862259,-0.00604811618778087,0.0156921501420197,0.384614224793275
CASQ2,Calsequestrin-2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39575,0.0079548888530981,0.00535270820367801,-0.00253641922611079,0.018446196932307,0.137270073111119
CASQ2,Calsequestrin-2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39575,0.00568473914349198,0.00452755188564384,-0.00318926255236995,0.0145587408393539,0.209292168958165
CASQ2,Calsequestrin-2,NMR metabolomics,X23558.Concentration of Large HDL Particles,39575,0.00216210937541177,0.00548562325970673,-0.00858971221361342,0.012913930964437,0.69348455450555
CASQ2,Calsequestrin-2,NMR metabolomics,X23559.Total Lipids in Large HDL,39575,0.00137044135746719,0.00543759190001441,-0.00928723876656105,0.0120281214814954,0.801021873916078
CASQ2,Calsequestrin-2,NMR metabolomics,X23560.Phospholipids in Large HDL,39575,0.000572249781787402,0.0053798611526119,-0.00997227807733193,0.0111167776409067,0.915291630690626
CASQ2,Calsequestrin-2,NMR metabolomics,X23561.Cholesterol in Large HDL,39575,0.00233520927256194,0.00552597445595299,-0.00849570066110592,0.0131661192062298,0.672604323364886
CASQ2,Calsequestrin-2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39575,0.00237234970202924,0.00554653716775283,-0.00849886314676631,0.0132435625508248,0.668865371228011
CASQ2,Calsequestrin-2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39575,0.00240661465180329,0.00545260397162926,-0.00828048913259005,0.0130937184361966,0.658954006440883
CASQ2,Calsequestrin-2,NMR metabolomics,X23564.Triglycerides in Large HDL,39575,0.00270061166969324,0.00476020255560562,-0.00662938533929378,0.0120306086786803,0.570500752697321
CASQ2,Calsequestrin-2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39575,-0.00147605592908857,0.00503808626104895,-0.0113507050007445,0.00839859314256737,0.76954336995213
CASQ2,Calsequestrin-2,NMR metabolomics,X23566.Total Lipids in Medium HDL,39575,-0.00170094417780846,0.00495198761295394,-0.0114068398991982,0.00800495154358127,0.731238575841166
CASQ2,Calsequestrin-2,NMR metabolomics,X23567.Phospholipids in Medium HDL,39575,-0.00147976551704284,0.00486412643593329,-0.0110134533314721,0.00805392229738641,0.760965904074538
CASQ2,Calsequestrin-2,NMR metabolomics,X23568.Cholesterol in Medium HDL,39575,-0.0020782428750761,0.00510037500600132,-0.0120749778868387,0.00791849213668649,0.683671768545342
CASQ2,Calsequestrin-2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39575,-0.00242525368435313,0.00509156650512159,-0.0124047240343914,0.00755421666568517,0.633850483340714
CASQ2,Calsequestrin-2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39575,-0.000453827421496085,0.00512505383963408,-0.0104989329471789,0.00959127810418671,0.929440556385771
CASQ2,Calsequestrin-2,NMR metabolomics,X23571.Triglycerides in Medium HDL,39575,0.00188297098919093,0.0048971521707488,-0.00771544726547673,0.0114813892438586,0.700612927763863
CASQ2,Calsequestrin-2,NMR metabolomics,X23572.Concentration of Small HDL Particles,39575,-0.0017351048742512,0.00472975394566432,-0.0110054226077533,0.00753521285925086,0.71373882710366
CASQ2,Calsequestrin-2,NMR metabolomics,X23573.Total Lipids in Small HDL,39575,-0.00154751634233033,0.00472686437001411,-0.010812170507558,0.00771713782289733,0.743381058434168
CASQ2,Calsequestrin-2,NMR metabolomics,X23574.Phospholipids in Small HDL,39575,-0.00157337054231475,0.0047003304941485,-0.0107860183108458,0.0076392772262163,0.737830524657627
CASQ2,Calsequestrin-2,NMR metabolomics,X23575.Cholesterol in Small HDL,39575,-0.00193905220932325,0.00470524012702054,-0.0111613228582835,0.00728321843963701,0.680270633112797
CASQ2,Calsequestrin-2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39575,-0.00271353761353538,0.00472443362020493,-0.011973427509137,0.00654635228206628,0.565734279673817
CASQ2,Calsequestrin-2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39575,0.000321497107837238,0.0046938628825951,-0.00887847414204915,0.00952146835772362,0.945394379329481
CASQ2,Calsequestrin-2,NMR metabolomics,X23578.Triglycerides in Small HDL,39575,0.00177025719379793,0.00526888323798939,-0.00855675395266126,0.0120972683402571,0.736889823115186
CASQ2,Calsequestrin-2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39250,-0.0123461608896112,0.00529398441420596,-0.0227223703414549,-0.00196995143776755,0.0197133777784999
CASQ2,Calsequestrin-2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39250,-0.00463736478055071,0.0050839164962918,-0.0146018411132826,0.00532711155218121,0.361703124173633
CASQ2,Calsequestrin-2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39250,-0.0026542444836713,0.00514602688745564,-0.0127404571830844,0.00743196821574176,0.606015150704821
CASQ2,Calsequestrin-2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39250,-0.00746805641254894,0.00506842588312076,-0.0174021711434656,0.00246605831836774,0.140660125934504
CASQ2,Calsequestrin-2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39250,0.00630386402612482,0.00514973222999783,-0.00378961114467092,0.0163973391969206,0.220935959343895
CASQ2,Calsequestrin-2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39512,0.00953658333547427,0.00516896495586071,-0.000594587978012717,0.0196677546489613,0.0650690380238096
CASQ2,Calsequestrin-2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39512,-0.00199106375288312,0.00523628434559079,-0.0122541810702411,0.00827205356447483,0.703771978015475
CASQ2,Calsequestrin-2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39512,-0.0033934930234796,0.00520952700225066,-0.0136041659478909,0.00681717990093169,0.514801144678592
CASQ2,Calsequestrin-2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39512,0.00461133206531376,0.00524273344382217,-0.00566442548457769,0.0148870896152052,0.379113628582023
CASQ2,Calsequestrin-2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39512,-0.001297336977071,0.00522362600064336,-0.011535643938332,0.00894096998418998,0.803860964331118
CASQ2,Calsequestrin-2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39575,0.0025135858881728,0.00541557514668779,-0.00810094139933527,0.0131281131756809,0.642556540013908
CASQ2,Calsequestrin-2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39575,0.000253526906119428,0.00505546355465669,-0.00965518166100769,0.0101622354732465,0.960004491885958
CASQ2,Calsequestrin-2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39575,-0.000559141095511616,0.00513913594512885,-0.0106318475479642,0.00951356535694094,0.913362633675688
CASQ2,Calsequestrin-2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39575,0.000712207325137647,0.00513265728688657,-0.00934780095716003,0.0107722156074353,0.889642380160972
CASQ2,Calsequestrin-2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39575,-0.00134943842373231,0.00515475800964782,-0.011452764122642,0.00875388727517742,0.793492102181355
CASQ2,Calsequestrin-2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39575,0.00416957937133413,0.00497164209278769,-0.00557483913052975,0.013913997873198,0.401671394718818
CASQ2,Calsequestrin-2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39575,0.00171490176865272,0.00514935749872884,-0.00837783892885581,0.0118076424661612,0.73911635134971
CASQ2,Calsequestrin-2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39575,0.000950901871368148,0.00517584652829373,-0.00919375732408756,0.0110955610668239,0.854237217494123
CASQ2,Calsequestrin-2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39575,0.00356953717152335,0.00503907126688295,-0.00630704251156722,0.0134461168546139,0.478729297975775
CASQ2,Calsequestrin-2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39575,-0.0021874480941954,0.00510326643655883,-0.0121898503098507,0.00781495412145991,0.668195929962906
CASQ2,Calsequestrin-2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39575,0.00251283001150977,0.00502244807260959,-0.00733116821080502,0.0123568282338246,0.616859974897908
CASQ2,Calsequestrin-2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39575,0.00226203287720992,0.00484929331761467,-0.00724258202531484,0.0117666477797347,0.640890880267478
CASQ2,Calsequestrin-2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39575,0.0021573222203039,0.00477147071353802,-0.00719476037823061,0.0115094048188384,0.651184696011851
CASQ2,Calsequestrin-2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39575,0.00265831570025631,0.00506527485258244,-0.00726962301080528,0.0125862544113179,0.599724671001094
CASQ2,Calsequestrin-2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39575,-0.00232359488840621,0.00489859157429209,-0.0119248343740187,0.00727764459720628,0.635267351102434
CASQ2,Calsequestrin-2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39575,0.000201537834928745,0.0047552194562913,-0.0091186922994022,0.00952176796925969,0.966194592302067
CASQ2,Calsequestrin-2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39575,0.00257268182749772,0.0050029366490899,-0.00723307400471849,0.0123784376597139,0.60709851533177
CASQ2,Calsequestrin-2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39575,0.00234593513133639,0.0050675891878899,-0.00758653967692781,0.0122784099396006,0.6434242777322
CASQ2,Calsequestrin-2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39575,0.00359943575041801,0.00442802951200098,-0.0050795020931039,0.0122783735939399,0.41630719865796
CASQ2,Calsequestrin-2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39575,-0.00301334273942919,0.0049433914925173,-0.0127023900647631,0.00667570458590471,0.542159363868187
CASQ2,Calsequestrin-2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39575,-0.00349066150353052,0.00466083792899122,-0.0126259038443533,0.00564458083729228,0.453912841580328
CASQ2,Calsequestrin-2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39575,0.00229644974386267,0.00486295352364067,-0.00723493916247304,0.0118278386501984,0.636769493272851
CASQ2,Calsequestrin-2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39575,0.00140453449195601,0.00481506687723564,-0.00803299658742584,0.0108420655713379,0.770524780268265
CASQ2,Calsequestrin-2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39575,0.0031207076884693,0.00447098554868049,-0.00564242398694445,0.0118838393638831,0.485197607930603
CASQ2,Calsequestrin-2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39575,-0.00157148559156582,0.00489721271786904,-0.0111700225185891,0.0080270513354575,0.748296921655259
CASQ2,Calsequestrin-2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39575,-0.0024869422686043,0.0047434746785373,-0.0117841526385374,0.00681026810132881,0.600089502075623
CASQ2,Calsequestrin-2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39575,0.00202505280713581,0.00484894715681489,-0.00747888362022137,0.011528989234493,0.676227788391376
CASQ2,Calsequestrin-2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39575,-0.000311001084273978,0.00461894495819792,-0.0093641332023419,0.00874213103379394,0.946318924912479
CASQ2,Calsequestrin-2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39575,0.00311768923844534,0.00518701753866581,-0.00704886513733965,0.0132842436142303,0.547814943990013
CASQ2,Calsequestrin-2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39575,-0.000168379327318823,0.00476577591107404,-0.00950930011302394,0.0091725414583863,0.971816497292662
CASQ2,Calsequestrin-2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39575,-0.00539311125691834,0.00487111187571228,-0.0149404905333144,0.00415426801947772,0.268248044283916
CASQ2,Calsequestrin-2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39575,0.00269064745322239,0.00480879951141314,-0.00673459958914736,0.0121158944955921,0.57581433813359
CASQ2,Calsequestrin-2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39575,0.00351147638625885,0.00486764853651932,-0.00602911474531902,0.0130520675178367,0.470684533881515
CASQ2,Calsequestrin-2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39575,-0.00370628511491491,0.00500937278410045,-0.0135246557717518,0.00611208554192197,0.459394647609583
CASQ2,Calsequestrin-2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39575,0.000914606455034471,0.0047515425057158,-0.0083984168561685,0.0102276297662374,0.847364922542582
CASQ2,Calsequestrin-2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39575,-0.00178724602090333,0.0048665070755963,-0.0113255998890721,0.00775110784726541,0.713436363321773
CASQ2,Calsequestrin-2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39575,-0.000558536735492482,0.00472800938375129,-0.009825435127645,0.00870836165666004,0.905963968450345
CASQ2,Calsequestrin-2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39575,0.00150483660542889,0.00482374497681316,-0.0079497035491249,0.0109593767599827,0.755073521036098
CASQ2,Calsequestrin-2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39575,-0.00376667454393294,0.00476472108020065,-0.0131055278611262,0.00557217877326034,0.429232990522738
CASQ2,Calsequestrin-2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39575,0.0027943589318268,0.00485161885499806,-0.00671481402396939,0.012303531887623,0.564651167532371
CASQ2,Calsequestrin-2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39565,0.00211007730686364,0.00514116742006466,-0.00796661083646309,0.0121867654501904,0.681500279624239
CASQ2,Calsequestrin-2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39565,-0.00229333175545344,0.00446491376356121,-0.0110445627320334,0.00645789922112653,0.607518215722942
CASQ2,Calsequestrin-2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39565,-0.0011257649233375,0.0041696994366413,-0.00929837581915444,0.00704684597247944,0.787175283763937
CASQ2,Calsequestrin-2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39565,-0.000458678018601774,0.00533183887957435,-0.0109090822225675,0.00999172618536395,0.931447133582121
CASQ2,Calsequestrin-2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39565,0.00176840016876753,0.00504931558258846,-0.00812825837310585,0.0116650587106409,0.726176035394809
CASQ2,Calsequestrin-2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39575,-0.00686503835058548,0.00477984346303265,-0.0162335315381295,0.00250345483695851,0.150960422117879
CASQ2,Calsequestrin-2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39575,0.0017696009559284,0.00505450045987453,-0.00813721994542567,0.0116764218572825,0.726267348624868
CASQ2,Calsequestrin-2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39575,0.000369042411159261,0.00486185576985973,-0.00916019489776581,0.00989827972008433,0.939495530789493
CASQ2,Calsequestrin-2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39575,0.00718558622474203,0.00481599682292901,-0.00225376754819884,0.0166249399976829,0.135721412367353
CASQ2,Calsequestrin-2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39575,0.00195286983379191,0.00485425335431946,-0.00756146674067424,0.0114672064082581,0.687470527088846
CASQ2,Calsequestrin-2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39575,0.00181025426851313,0.00517928021038344,-0.00834113494383842,0.0119616434808647,0.726706787969545
CASQ2,Calsequestrin-2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39575,-0.0029079254033166,0.00516275023172672,-0.013026915857501,0.00721106505086777,0.573275331222209
CASQ2,Calsequestrin-2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39575,-0.0043776738834315,0.00489674626252919,-0.0139752965579887,0.00521994879112571,0.371343382453435
CASQ2,Calsequestrin-2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39575,0.00339426822388634,0.0054142115026408,-0.00721758632128962,0.0140061227690623,0.530725837155329
CASQ2,Calsequestrin-2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39575,0.00330579736512576,0.00508361707858687,-0.0066580921089045,0.013269686839156,0.515522082198396
CASQ2,Calsequestrin-2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39575,-0.00185422581544003,0.00469636421878734,-0.0110590996842632,0.00735064805338317,0.692982259794719
CASQ2,Calsequestrin-2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39575,-0.000502842998310992,0.00466631504857881,-0.00964882049352546,0.00864313449690348,0.914187892161193
CASQ2,Calsequestrin-2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39575,-0.00201645216913155,0.00459253575653514,-0.0110178222519404,0.00698491791367731,0.660618277319471
CASQ2,Calsequestrin-2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39575,0.00619313453049577,0.00501023538152311,-0.00362692681728953,0.0160131958782811,0.216449141775437
CASQ2,Calsequestrin-2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39575,0.00322466147625016,0.00527830466524968,-0.00712081566763922,0.0135701386201395,0.541260229745063
CASQ2,Calsequestrin-2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48148,0.00380555323206734,0.00399194174104689,-0.00401865258038456,0.0116297590445192,0.34044541640498
CASQ2,Calsequestrin-2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48148,0.00378688033971592,0.00389419850502219,-0.00384574873012757,0.0114195094095594,0.330842973803259
CASQ2,Calsequestrin-2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46784,0.00404614602019263,0.00371617147287213,-0.00323755006663674,0.011329842107022,0.276259070642723
CASQ2,Calsequestrin-2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46784,0.00374959574880516,0.00405141507902427,-0.0041911778060824,0.0116903693036927,0.354716742171286
CASQ2,Calsequestrin-2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46784,0.00145581784009136,0.00399746348431172,-0.00637921058915961,0.00929084626934232,0.715723802685957
CASQ2,Calsequestrin-2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46784,0.00677334021050032,0.00368654142162615,-0.000452280975886939,0.0139989613968876,0.0661796202906252
CASQ2,Calsequestrin-2,Working and living environment,X24009.Traffic intensity on the nearest road,48148,0.152886305118312,0.0531130019588957,0.0487848212788764,0.256987788957748,0.00399991838724517
CASQ2,Calsequestrin-2,Working and living environment,X24010.Inverse distance to the nearest road,48148,-1.28657212697778e-05,0.00350258149651295,-0.00687792545443516,0.00685219401189561,0.997069245638752
CASQ2,Calsequestrin-2,Working and living environment,X24011.Traffic intensity on the nearest major road,48148,0.00275501776805966,0.00346728212251315,-0.00404085519206611,0.00955089072818543,0.426870063510559
CASQ2,Calsequestrin-2,Working and living environment,X24012.Inverse distance to the nearest major road,48148,0.00572579651151956,0.00354943624045627,-0.00123109851977473,0.0126826915428138,0.106726630627698
CASQ2,Calsequestrin-2,Working and living environment,X24013.Total traffic load on major roads,48148,0.0598180542737122,0.0403557632171805,-0.0192792416319616,0.138915350179386,0.13828513421293
CASQ2,Calsequestrin-2,Working and living environment,X24015.Sum of road length of major roads within 100m,48148,0.0529561913234791,0.0393452319018392,-0.0241604632041257,0.130072845851084,0.178338543522166
CASQ2,Calsequestrin-2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48148,-0.00161095910158979,0.00401889650287217,-0.00948799624721924,0.00626607804403967,0.688537796025893
CASQ2,Calsequestrin-2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48148,-0.000487052995558159,0.00401761263903653,-0.00836157376806975,0.00738746777695343,0.90351053950813
CASQ2,Calsequestrin-2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48148,-0.00160348420887224,0.00396845769041036,-0.00938166128207654,0.00617469286433206,0.686175020730476
CASQ2,Calsequestrin-2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48111,-0.00222817280581033,0.00387082052082118,-0.00981498102661985,0.00535863541499919,0.564869773755403
CASQ2,Calsequestrin-2,Working and living environment,X24020.Average daytime sound level of noise pollution,48148,0.00688548373896911,0.00348557568147496,5.37554032781912e-05,0.01371721207466,0.0482342938542064
CASQ2,Calsequestrin-2,Working and living environment,X24021.Average evening sound level of noise pollution,48148,0.00692798098202141,0.00348615194052582,9.51231785907922e-05,0.013760838785452,0.0469046429802442
CASQ2,Calsequestrin-2,Working and living environment,X24022.Average night-time sound level of noise pollution,48148,0.00687585457773534,0.00348561855558693,4.404220878496e-05,0.0137076669466857,0.0485511853576053
CASQ2,Calsequestrin-2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48148,0.00687944375413245,0.00348590663384068,4.70667518047184e-05,0.0137118207564602,0.0484524569191335
CASQ2,Calsequestrin-2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48148,0.00689418919063833,0.00348600064882496,6.16279189414081e-05,0.0137267504623352,0.0479789883700336
CASQ2,Calsequestrin-2,Health and medical history,X2405.Number of children fathered,48139,0.0196025786126903,0.0314159208002597,-0.0419726261558186,0.0811777833811992,0.532654854099457
CASQ2,Calsequestrin-2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45919,-0.00220436543217142,0.00417724050145827,-0.0103917568150296,0.00598302595068679,0.597708414315745
CASQ2,Calsequestrin-2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45919,0.00161436026068103,0.00375183883508522,-0.005739243856086,0.00896796437744806,0.666993635395557
CASQ2,Calsequestrin-2,Working and living environment,"X24502.Water percentage, buffer 1000m",45919,-0.000634422651338017,0.00378215811855227,-0.00804745256370047,0.00677860726102444,0.866789067763491
CASQ2,Calsequestrin-2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45919,-0.00310808773224025,0.0039115038808225,-0.0107746353386524,0.00455845987417186,0.426856102591196
CASQ2,Calsequestrin-2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45919,0.000104641880668671,0.0037874318283581,-0.0073187245029132,0.00752800826425054,0.977958596192524
CASQ2,Calsequestrin-2,Working and living environment,"X24505.Water percentage, buffer 300m",45919,-0.00330831676357809,0.00381173895072152,-0.0107793251069923,0.00416269157983608,0.385445516872973
CASQ2,Calsequestrin-2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48216,-0.00214955475755882,0.00394004228139561,-0.00987203762909421,0.00557292811397658,0.585370216551767
CASQ2,Calsequestrin-2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48216,8.02694485560989e-05,0.00369410765768877,-0.00716018156051389,0.00732072045762608,0.982664312011772
CASQ2,Calsequestrin-2,Working and living environment,X24508.Distance (Euclidean) to coast,48216,0.00177970461640769,0.00349722714128046,-0.005074860580502,0.00863426981331739,0.610834913780236
CASQ2,Calsequestrin-2,Lifestyle factors,X2867.Age started smoking in former smokers,34410,0.00184721946140338,0.00630061223937051,-0.0105019805277628,0.0141964194505696,0.769394317553555
CASQ2,Calsequestrin-2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35504,-0.0852494339711169,0.0645603840623937,-0.211787786733409,0.0412889187911747,0.186725115518157
CASQ2,Calsequestrin-2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35505,-0.0112641770321719,0.0708397175082131,-0.15011002334827,0.127581669283926,0.873666163494382
CASQ2,Calsequestrin-2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35505,-0.0307439586981498,0.0667162910047996,-0.161507889067557,0.100019971671257,0.644944876756236
CASQ2,Calsequestrin-2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35495,-0.0949429830280284,0.0701999122504035,-0.232534811038819,0.0426488449827625,0.176270705854302
CASQ2,Calsequestrin-2,Mental health,X28739.Difficulty with standing for long periods,35511,0.0219319880089468,0.0556022828833038,-0.0870484864423287,0.130912462460222,0.693265425477072
CASQ2,Calsequestrin-2,Mental health,X28740.Difficulty with taking care of household responsibilities,35524,-0.0907571329111557,0.0697188195898896,-0.227406019307339,0.045891753485028,0.193041951869724
CASQ2,Calsequestrin-2,Mental health,X28741.Difficulty learning a new task,35488,-0.0802141907507708,0.081500865446413,-0.23995588702574,0.0795275055241987,0.325045503318585
CASQ2,Calsequestrin-2,Mental health,X28742.Difficulty with joining in community activities,35134,-0.038890496669093,0.0732690659131495,-0.182497865858866,0.10471687252068,0.595582271906888
CASQ2,Calsequestrin-2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35482,-0.0332929282274304,0.0631883946709664,-0.157142181782525,0.0905563253276638,0.598291419519812
CASQ2,Calsequestrin-2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35532,-0.0679279422334602,0.0880821899435297,-0.240569034522778,0.104713150055858,0.440621706124984
CASQ2,Calsequestrin-2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,33913,0.113041832509395,0.0611933337342377,-0.00689710160971081,0.232980766628501,0.064760694072152
CASQ2,Calsequestrin-2,Lifestyle factors,X2897.Age stopped smoking,34402,0.00492634766252092,0.00664481562995924,-0.00809749097219919,0.017950186297241,0.458491773585894
CASQ2,Calsequestrin-2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34709,0.00401998028362943,0.0144684845534177,-0.0243382494410692,0.0323782100083281,0.781141586626919
CASQ2,Calsequestrin-2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34709,-0.00767221072881257,0.0162701580315889,-0.0395617204707269,0.0242172990131017,0.63726408571436
CASQ2,Calsequestrin-2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34709,0.0315218840239427,0.0536341308498482,-0.0736010124417599,0.136644780489645,0.556741563365509
CASQ2,Calsequestrin-2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34709,-0.00339085220488072,0.0548566338268271,-0.110909854505462,0.1041281500957,0.950713785996758
CASQ2,Calsequestrin-2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34709,0.145406469323828,0.0658661153502913,0.016308883237257,0.274504055410399,0.0273087388183209
CASQ2,Calsequestrin-2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34709,0.0148798150034191,0.0605685206112403,-0.103834485394612,0.13359411540145,0.805946633057873
CASQ2,Calsequestrin-2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34709,-0.0171334960954461,0.0247059153838337,-0.0655570902477601,0.0312900980568679,0.488023619472176
CASQ2,Calsequestrin-2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34709,0.0145445916698995,0.0476553385812556,-0.0788598719493616,0.10794905528916,0.760221316357958
CASQ2,Calsequestrin-2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34683,0.00105012045817563,0.0646498950841383,-0.125663673906736,0.127763914823087,0.987040913115958
CASQ2,Calsequestrin-2,Mental health,X29003.Recent feelings of depression,34683,0.0237148497119479,0.0631709421248418,-0.100100196852742,0.147529896276638,0.707370471282495
CASQ2,Calsequestrin-2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34684,0.0615824127175157,0.0491386938689681,-0.0347294272656618,0.157894252700693,0.210167766948601
CASQ2,Calsequestrin-2,Mental health,X29005.Recent feelings of tiredness or low energy,34685,0.0437891406457834,0.0485015110419114,-0.0512738209963629,0.13885210228793,0.366646168604481
CASQ2,Calsequestrin-2,Mental health,X29006.Recent poor appetite or overeating,34692,0.0366775652664471,0.0760109840840094,-0.112303963538211,0.185659094071105,0.629446974219168
CASQ2,Calsequestrin-2,Mental health,X29007.Recent feelings of inadequacy,34674,0.0238489498233924,0.069707597913088,-0.11277794208626,0.160475841733045,0.732266096910538
CASQ2,Calsequestrin-2,Mental health,X29008.Recent trouble concentrating on things,34690,-0.054958496398975,0.0714683275362841,-0.195036418370092,0.0851194255721419,0.441928519752342
CASQ2,Calsequestrin-2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34685,0.0338072188658468,0.114784960500011,-0.191171303714175,0.258785741445868,0.7683656256737
CASQ2,Calsequestrin-2,Mental health,X29010.Recent thoughts of suicide or self-harm,34670,-0.162091239776365,0.145028577871923,-0.446347252405333,0.122164772852604,0.263760606402499
CASQ2,Calsequestrin-2,Mental health,X29038#0.Substances taken for depression_None of options listed,34736,-0.0200845346636309,0.0265446600984431,-0.0721120684565793,0.0319429991293176,0.449299517611469
CASQ2,Calsequestrin-2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),34736,0.0102088174326497,0.0473711226032992,-0.0826385828698168,0.103056217735116,0.829379071099041
CASQ2,Calsequestrin-2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),34736,0.00730055356677397,0.0300230975109361,-0.0515447175546608,0.0661458246882088,0.807886041239121
CASQ2,Calsequestrin-2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),34736,0.0353380697294982,0.0901327002966187,-0.141322022851874,0.211998162310871,0.695022225148226
CASQ2,Calsequestrin-2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),34736,-0.0104874532286566,0.058755615671002,-0.125648459943821,0.104673553486507,0.858341882874639
CASQ2,Calsequestrin-2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),34736,0.0170677581657327,0.0709773907651924,-0.122047927734044,0.15618344406551,0.809975862031796
CASQ2,Calsequestrin-2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),34736,-0.113510956344835,0.0710081114465182,-0.252686854780011,0.0256649420903401,0.10996917215877
CASQ2,Calsequestrin-2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),34736,-0.0533173923978927,0.0821313250385439,-0.214294789473439,0.107660004677653,0.516251222664383
CASQ2,Calsequestrin-2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),34736,0.045986016918462,0.0581817989923331,-0.068050309106511,0.160022342943435,0.429333547555644
CASQ2,Calsequestrin-2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,34736,-0.0121594918842827,0.0249949066945308,-0.0611495090055632,0.0368305252369977,0.626645116431862
CASQ2,Calsequestrin-2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,34736,0.0500241552090409,0.0401610719259356,-0.0286915457657928,0.128739856183875,0.212963195669905
CASQ2,Calsequestrin-2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,34736,-0.0757244032037701,0.0650339872085119,-0.203191018132453,0.0517422117249133,0.244314513511916
CASQ2,Calsequestrin-2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,34736,-0.0952579290669517,0.0778636377474643,-0.247870659051982,0.0573548009180784,0.221227791712072
CASQ2,Calsequestrin-2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,34736,-0.0719020191430231,0.0499446397938179,-0.169793513138906,0.0259894748528601,0.150021888504952
CASQ2,Calsequestrin-2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,34736,0.00262946310502505,0.0733745501477071,-0.141184655184481,0.146443581394531,0.971414155046826
CASQ2,Calsequestrin-2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,34736,-0.0261280715726591,0.0710726315344311,-0.165430429380144,0.113174286234826,0.713165598515956
CASQ2,Calsequestrin-2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,34736,-0.0523264510328406,0.0407178921430511,-0.132133519633221,0.0274806175675396,0.198806809020144
CASQ2,Calsequestrin-2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,34736,-0.0105150528417084,0.0397116508952276,-0.0883498885963544,0.0673197829129376,0.791183921399399
CASQ2,Calsequestrin-2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,34736,-0.0514671612156176,0.0595583185847975,-0.168201465641821,0.0652671432105854,0.387540747347445
CASQ2,Calsequestrin-2,Mental health,X29058.Recent feelings or nervousness or anxiety,34590,-0.108912145564085,0.0671908985013041,-0.240606306626641,0.0227820154984711,0.105084019377771
CASQ2,Calsequestrin-2,Mental health,X29059.Recent inability to stop or control worrying,34593,0.0099572821347257,0.0660337277548609,-0.119468824264802,0.139383388534253,0.880145778615352
CASQ2,Calsequestrin-2,Mental health,X29060.Recent worrying too much about different things,34594,0.00678775209554091,0.0592391639338743,-0.109321009214853,0.122896513405934,0.908780150085784
CASQ2,Calsequestrin-2,Mental health,X29061.Recent trouble relaxing,34591,-0.0170925325468083,0.0639180710426686,-0.142371951790439,0.108186886696822,0.789160285871893
CASQ2,Calsequestrin-2,Mental health,X29062.Recent restlessness,34597,-0.011701117696287,0.0891130371467058,-0.18636267050383,0.162960435111256,0.895537285525199
CASQ2,Calsequestrin-2,Mental health,X29063.Recent easy annoyance or irritability,34588,0.0203479920634065,0.0598070300189503,-0.0968737867737361,0.137569770900549,0.733697201673325
CASQ2,Calsequestrin-2,Mental health,X29064.Recent feelings of foreboding,34592,-0.00946105266096844,0.0766103808377156,-0.159617399102891,0.140695293780954,0.901718721999873
CASQ2,Calsequestrin-2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,34736,-0.0249564557930523,0.031310108805769,-0.0863242690523596,0.036411357466255,0.425439227551792
CASQ2,Calsequestrin-2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,34736,-0.0397177117347429,0.0477846539269187,-0.133375633431504,0.0539402099620176,0.405903547583508
CASQ2,Calsequestrin-2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',34736,-0.0333603618471275,0.0669139185836243,-0.164511642271031,0.0977909185767762,0.618109802791557
CASQ2,Calsequestrin-2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,34736,-0.0283903363909729,0.0639586663238955,-0.153749322385808,0.0969686496038622,0.657140887146215
CASQ2,Calsequestrin-2,Mental health,X29065#2.Symptoms of panic attack_Sweating,34736,0.0315727143755838,0.0417976760875371,-0.0503507307559889,0.113496159507156,0.450055947519902
CASQ2,Calsequestrin-2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,34736,-0.0330760001103894,0.0518207426565766,-0.13464465571728,0.0684926554965008,0.523317051223121
CASQ2,Calsequestrin-2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,34736,-0.0215948066933172,0.0482681011120453,-0.116200284872926,0.0730106714862916,0.654607179345988
CASQ2,Calsequestrin-2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,34736,0.0198128283886432,0.0507679464821721,-0.079692346716414,0.1193180034937,0.696355957668287
CASQ2,Calsequestrin-2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,34736,0.0756176039967259,0.0595850650162794,-0.0411691234351818,0.192404331428634,0.204464321243606
CASQ2,Calsequestrin-2,Mental health,X29076.Felt loved as a child,34566,0.0407488308250429,0.0517710000370992,-0.0607223292476714,0.142219990897757,0.431256005066727
CASQ2,Calsequestrin-2,Mental health,X29077.Physically abused by family as a child,34574,-0.0206553292971452,0.0674498939498415,-0.152857121438835,0.111546462844544,0.759438535347083
CASQ2,Calsequestrin-2,Mental health,X29078.Felt hated by family member as a child,34567,0.0187419001723526,0.0750221435120109,-0.128301501111189,0.165785301455894,0.802736514060992
CASQ2,Calsequestrin-2,Mental health,X29079.Sexually molested as a child,34552,-0.0556738387491419,0.11827580252826,-0.287494411704532,0.176146734206248,0.637863676541461
CASQ2,Calsequestrin-2,Mental health,X29080.Someone to take to doctor when needed as a child,34562,-0.0231902827436311,0.0778283176610248,-0.17573378535924,0.129353219871977,0.765738616552882
CASQ2,Calsequestrin-2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34573,0.0884969715341043,0.109693046393079,-0.12650139939633,0.303495342464539,0.419831593024639
CASQ2,Calsequestrin-2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34559,0.0815749684792042,0.0895663608462939,-0.0939750987795318,0.25712503573794,0.362449805086283
CASQ2,Calsequestrin-2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34583,0.00201750550549539,0.108241569485751,-0.210135970686577,0.214170981697567,0.985129779473692
CASQ2,Calsequestrin-2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34576,-0.0196015572034475,0.353611424568437,-0.712679949357584,0.673476834950689,0.955795775972829
CASQ2,Calsequestrin-2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34569,0.13330114626822,0.181933153286239,-0.22328783417281,0.489890126709249,0.463774474670478
CASQ2,Calsequestrin-2,Mental health,X29086.Experienced a violent or sexual assault,34585,-0.0740355411810042,0.124846121602764,-0.318733939522421,0.170662857160413,0.55319396155057
CASQ2,Calsequestrin-2,Mental health,X29087.Experienced a life-threatening injury or illness,34578,-0.09078083301111,0.0608010939781536,-0.209950977208291,0.028389311186071,0.135469306560287
CASQ2,Calsequestrin-2,Mental health,X29088.Experienced a marital separation or divorce,34578,-0.0690382968066958,0.0600501282198553,-0.186736548117612,0.0486599545042205,0.250322617938101
CASQ2,Calsequestrin-2,Mental health,X29089.Experienced the death of a spouse or partner,34589,0.101175152176586,0.0799735212496158,-0.0555729494726607,0.257923253825833,0.205881796561408
CASQ2,Calsequestrin-2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34579,-0.0520523147737326,0.0743994827546004,-0.197875300972749,0.0937706714252842,0.484183906371537
CASQ2,Calsequestrin-2,Lifestyle factors,X29091.Frequency of drinking alcohol,34574,0.0231886398113379,0.0462124895370491,-0.0673878396812783,0.113765119303954,0.615838701327624
CASQ2,Calsequestrin-2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34076,0.0355880363659215,0.0507621439199498,-0.0639057657171801,0.135081838449023,0.483286430929514
CASQ2,Calsequestrin-2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34095,0.0373807666526542,0.050530260853942,-0.0616585446210721,0.13642007792638,0.459471238059504
CASQ2,Calsequestrin-2,Mental health,X29104.Ever used cannabis,34571,-0.0113242821109108,0.0648281572004117,-0.138387470223718,0.115738906001896,0.861335801794274
CASQ2,Calsequestrin-2,Mental health,X29108.Ever thought that life not worth living,34551,-0.0825556286484661,0.0669316965491629,-0.213741753884825,0.0486304965878932,0.217463732417482
CASQ2,Calsequestrin-2,Mental health,X29109.Ever contemplated self-harm,34555,-0.0973620895722076,0.0973699748686475,-0.288207240314757,0.0934830611703414,0.317390335429609
CASQ2,Calsequestrin-2,Mental health,X29111.Ever self-harmed,34566,-0.177180487205523,0.184747752938144,-0.539286082964286,0.18492510855324,0.337577458421544
CASQ2,Calsequestrin-2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34568,-0.0187798041648734,0.101527122523443,-0.217772964310822,0.180213355981075,0.85325628520257
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,35229,-0.115760536566683,0.0672840473104409,-0.247637269295147,0.0161161961617809,0.0853927605622908
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,35229,0.00666854041145388,0.0529263571642432,-0.0970671196304628,0.110404200453371,0.899738446518551
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,35229,-0.0201322716944002,0.0626986159894134,-0.14302155903365,0.10275701564485,0.748147801462525
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,35229,-0.211548719202472,0.107882104316508,-0.422997643662828,-9.97947421166323e-05,0.0499295756944856
CASQ2,Calsequestrin-2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34555,-0.0105710486747248,0.0540205221690154,-0.116451272125995,0.0953091747765453,0.844862783293897
CASQ2,Calsequestrin-2,Health and medical history,X29153.Pain or discomfort today,34568,0.0158602460557972,0.0481881632156313,-0.0785885538468403,0.110309045958435,0.742067794287937
CASQ2,Calsequestrin-2,Mental health,X29154.Anxiety or depression today,34568,-0.0333584278031603,0.0685956447561285,-0.167805891525172,0.101089035918852,0.626768564398898
CASQ2,Calsequestrin-2,Mental health,X29166.Frequency of confiding in someone close,34418,0.0015819556299688,0.0493153867009691,-0.0950762023039306,0.0982401135638682,0.974410679614506
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34555,-0.00353854902949924,0.0137110484713923,-0.0304122040334282,0.0233351059744297,0.796353992575263
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34555,0.0234026538814781,0.0142078263527849,-0.00444468576998025,0.0512499935329365,0.0995766140011338
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34555,0.00234281446548701,0.015076322717772,-0.0272067780613461,0.0318924069923201,0.876513660689143
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34555,-0.0341512004680613,0.0206776439203139,-0.0746793825518764,0.00637698161575391,0.098668807887006
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34555,0.0372899573674911,0.0414086663619957,-0.0438710287020205,0.118450943437003,0.367871972661388
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34555,-0.0125062790626602,0.0152673423878229,-0.0424302701427932,0.0174177120174727,0.41273229037143
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34548,-0.00365687868149999,0.0159887714629103,-0.0349948707488042,0.0276811133858042,0.819097966951351
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34548,0.0405927537132359,0.0252962092039553,-0.00898781632651653,0.0901733237529883,0.108613568666128
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34548,0.0162881860026326,0.0285033825411715,-0.0395784437780634,0.0721548157833287,0.567717946652551
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34548,-0.0603810883852203,0.034988027713505,-0.12895762270369,0.00819544593324956,0.084441764030261
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34548,0.0632728034069646,0.0599965028007281,-0.0543203420824624,0.180865948896392,0.291647390782122
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34548,-0.0219953508833593,0.0228872012607671,-0.0668542653544628,0.0228635635877443,0.33657474601978
CASQ2,Calsequestrin-2,Mental health,X29171.Frequency of feeling 'in tune' with people,34404,0.0347192031203186,0.0613882041472028,-0.0856016770081988,0.155040083248836,0.571709360417615
CASQ2,Calsequestrin-2,Mental health,X29172.Freuency of feeling that lacks companionship,34514,-0.0325235245755637,0.0570036773909075,-0.144250732261742,0.079203683110615,0.568325490458323
CASQ2,Calsequestrin-2,Mental health,X29173.Frequency of feeling left out,34489,0.0726627549073653,0.0571780586864635,-0.0394062401181031,0.184731749932834,0.203844551023281
CASQ2,Calsequestrin-2,Mental health,X29174.Frequency of feeling isolated from others,34518,-0.0626421938551876,0.0618066105783813,-0.183783150588815,0.0584987628784397,0.31085361467036
CASQ2,Calsequestrin-2,Mental health,X29175.Tendency to bounce back quickly after hard times,34561,-0.0360879102438358,0.0477778072271111,-0.129732412408974,0.0575565919213019,0.450082127017947
CASQ2,Calsequestrin-2,Mental health,X29176.Ability to make it through stressful events,34561,-0.0556695547241954,0.046874577189619,-0.147543726015849,0.0362046165674579,0.235027392579378
CASQ2,Calsequestrin-2,Mental health,X29177.Quick recovery from stressful events,34561,0.0230390319040869,0.0482164406361122,-0.0714651917426931,0.117543255550867,0.632792130694721
CASQ2,Calsequestrin-2,Mental health,X29178.Hard to snap back when something bad happens,34561,-0.0304213601310414,0.0467200362539383,-0.121992631188761,0.0611499109266777,0.514980183305134
CASQ2,Calsequestrin-2,Mental health,X29179.Comes through difficult times with little trouble,34561,0.000131098393934283,0.0476988502878216,-0.093358648170196,0.0936208449580646,0.997807140777981
CASQ2,Calsequestrin-2,Mental health,X29180.Tendency to take a long time to get over setbacks,34561,-0.052234799314304,0.0474079191893576,-0.145154320925445,0.0406847222968368,0.27058622214907
CASQ2,Calsequestrin-2,Mental health,X29181.General happiness,34528,-0.0290764662781544,0.049241381274052,-0.125589573575296,0.0674366410189876,0.554885760081903
CASQ2,Calsequestrin-2,Mental health,X29182.Belief that own life is meaningful,34448,0.0482246907044013,0.0497791676718054,-0.0493424779323374,0.14579185934114,0.332698774433268
CASQ2,Calsequestrin-2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,33849,0.000932042752302747,0.0561904490374118,-0.109201237361024,0.11106532286563,0.986766558999577
CASQ2,Calsequestrin-2,Health and medical history,X2946.Father's age,32762,-0.00265766854852522,0.0113165818779444,-0.0248381690292962,0.0195228319322458,0.814338817307012
CASQ2,Calsequestrin-2,Health and medical history,X2966.Age high blood pressure diagnosed,34327,0.007543336816814,0.00947099409245715,-0.011019811604402,0.02610648523803,0.425793505927555
CASQ2,Calsequestrin-2,Blood and urine assays,X30000.White blood cell (leukocyte) count,47830,0.00456292229883954,0.00372432727558532,-0.00273675916130768,0.0118626037589868,0.220527369587374
CASQ2,Calsequestrin-2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47831,-0.00248961585395633,0.00404259796252919,-0.0104131078605135,0.00543387615260089,0.538003767973163
CASQ2,Calsequestrin-2,Blood and urine assays,X30020.Haemoglobin concentration,47831,0.000943725274610643,0.00428295612775233,-0.00745086873578391,0.0093383192850052,0.825605304999328
CASQ2,Calsequestrin-2,Blood and urine assays,X30030.Haematocrit percentage,47831,-0.000708308581509784,0.00420027356018302,-0.0089408447594685,0.00752422759644893,0.866086374428501
CASQ2,Calsequestrin-2,Blood and urine assays,X30040.Mean corpuscular volume,47831,0.00478099208086022,0.00368782476109383,-0.0024471444508837,0.0120091286126041,0.194844299138584
CASQ2,Calsequestrin-2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47831,0.00646063422173532,0.00369422823576686,-0.000780053120367716,0.0137013215638384,0.0803336924275532
CASQ2,Calsequestrin-2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47831,0.00413826024547417,0.00359986819012071,-0.00291748140716243,0.0111940018981108,0.250339921318112
CASQ2,Calsequestrin-2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47831,0.00238942094147151,0.00376329842998483,-0.00498664398129877,0.00976548586424178,0.525483379468078
CASQ2,Calsequestrin-2,Blood and urine assays,X30080.Platelet count,47831,0.00042377829768818,0.00368357009673705,-0.00679601909191644,0.0076435756872928,0.908410229903688
CASQ2,Calsequestrin-2,Blood and urine assays,X30090.Platelet crit,47831,-0.000485643483011298,0.00375424674064073,-0.00784396709466713,0.00687268012864454,0.897075388168147
CASQ2,Calsequestrin-2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47831,-0.00203413122618379,0.00348221619966551,-0.00885927497752818,0.0047910125251606,0.55912728630086
CASQ2,Calsequestrin-2,Blood and urine assays,X30110.Platelet distribution width,47831,6.42316428583913e-05,0.00358730410082782,-0.00696688439476414,0.00709534768048092,0.985714611839601
CASQ2,Calsequestrin-2,Blood and urine assays,X30120.Lymphocyte count,47799,0.00549731797606938,0.00361454651034377,-0.00158719318420442,0.0125818291363432,0.128304583226749
CASQ2,Calsequestrin-2,Blood and urine assays,X30130.Monocyte count,47799,0.00577763048528316,0.00364813536688328,-0.00137271483380807,0.0129279758043744,0.113273576387004
CASQ2,Calsequestrin-2,Blood and urine assays,X30140.Neutrophill count,47799,0.00282142209290303,0.00368835137422262,-0.0044077466005733,0.0100505907863794,0.444307861940739
CASQ2,Calsequestrin-2,Blood and urine assays,X30150.Eosinophill count,47799,0.0103829150256072,0.00349710383622216,0.00352859150661176,0.0172372385446026,0.00299135834049766
CASQ2,Calsequestrin-2,Blood and urine assays,X30160.Basophill count,47799,0.0409253915473196,0.0305766349127483,-0.0190048128816671,0.100855595976306,0.180764632178782
CASQ2,Calsequestrin-2,Blood and urine assays,X30170.Nucleated red blood cell count,47799,0.0970625066827126,0.145353942643849,-0.187831220899232,0.381956234264657,0.504290623015902
CASQ2,Calsequestrin-2,Blood and urine assays,X30180.Lymphocyte percentage,47800,0.000541153637868321,0.00358490601712311,-0.00648526215569296,0.00756756943142961,0.880014086901953
CASQ2,Calsequestrin-2,Blood and urine assays,X30190.Monocyte percentage,47800,0.00326578658030058,0.00360377942696667,-0.00379762109655411,0.0103291942571553,0.364835257031138
CASQ2,Calsequestrin-2,Blood and urine assays,X30200.Neutrophill percentage,47800,-0.00257883083007385,0.00353781548502091,-0.00951294918071483,0.00435528752056713,0.466051473666883
CASQ2,Calsequestrin-2,Blood and urine assays,X30210.Eosinophill percentage,47800,0.0087935345479103,0.00347173380054105,0.00198893629884984,0.0155981327969708,0.0113204015355927
CASQ2,Calsequestrin-2,Blood and urine assays,X30220.Basophill percentage,47800,0.00315714848619576,0.00363837706030347,-0.00397407055199904,0.0102883675243906,0.385550059957237
CASQ2,Calsequestrin-2,Blood and urine assays,X30230.Nucleated red blood cell percentage,47799,0.107356995612614,0.145170177753486,-0.177176552784218,0.391890544009446,0.459597223808635
CASQ2,Calsequestrin-2,Blood and urine assays,X30240.Reticulocyte percentage,47491,-0.00802501386580981,0.00383425303401561,-0.0155401498124804,-0.000509877919139207,0.036364269138671
CASQ2,Calsequestrin-2,Blood and urine assays,X30250.Reticulocyte count,47491,-0.00851942593574705,0.00387383920343677,-0.0161121507744831,-0.000926701097010985,0.0278743327195554
CASQ2,Calsequestrin-2,Blood and urine assays,X30260.Mean reticulocyte volume,47491,0.00111447778797147,0.00363573821273172,-0.00601156910898271,0.00824052468492565,0.75920138898946
CASQ2,Calsequestrin-2,Blood and urine assays,X30270.Mean sphered cell volume,47491,0.0018978392525439,0.00365224946039124,-0.00526056968982294,0.00905624819491074,0.603323590010446
CASQ2,Calsequestrin-2,Blood and urine assays,X30280.Immature reticulocyte fraction,47491,0.00187944566772641,0.00377601135007577,-0.0055215365784221,0.00928042791387493,0.618677999582182
CASQ2,Calsequestrin-2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47491,-0.00561518913837693,0.00388520526971048,-0.0132301914670095,0.00199981319025562,0.148397310266318
CASQ2,Calsequestrin-2,Blood and urine assays,X30300.High light scatter reticulocyte count,47491,-0.006006268749722,0.00390186633385127,-0.0136539267640705,0.00164138926462649,0.123739949237912
CASQ2,Calsequestrin-2,Blood and urine assays,X30500.Microalbumin in urine,35632,0.0115903615122571,0.0057671729472324,0.000286702535681636,0.0228940204888326,0.0444997197713674
CASQ2,Calsequestrin-2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47887,-0.000557773575654775,0.00388535931397337,-0.00817307783104259,0.00705753067973304,0.885851178002378
CASQ2,Calsequestrin-2,Blood and urine assays,X30520.Potassium in urine,47849,-0.000345978995669749,0.00362195099323816,-0.00744500294241654,0.00675304495107704,0.923900554726283
CASQ2,Calsequestrin-2,Blood and urine assays,X30530.Sodium in urine,47858,-0.00482142507204461,0.0037584077270264,-0.0121879042170164,0.00254505407292713,0.199564573320367
CASQ2,Calsequestrin-2,Blood and urine assays,X30600.Albumin,46026,-0.00430720072707963,0.00382076248892756,-0.0117958952053776,0.00318149375121838,0.259625081130512
CASQ2,Calsequestrin-2,Blood and urine assays,X30610.Alkaline phosphatase,47466,0.0123165174553988,0.00379529540531127,0.00487773846098874,0.0197552964498089,0.00117569963627045
CASQ2,Calsequestrin-2,Blood and urine assays,X30620.Alanine aminotransferase,47451,-0.00126231222433146,0.00408954659173995,-0.00927782354414176,0.00675319909547884,0.757577488526493
CASQ2,Calsequestrin-2,Blood and urine assays,X30630.Apolipoprotein A,45974,-0.0100401041756225,0.00414091766256681,-0.0181563027942535,-0.00192390555699159,0.0153350335755515
CASQ2,Calsequestrin-2,Blood and urine assays,X30640.Apolipoprotein B,47328,0.00390378932388848,0.00355605698514279,-0.00306608236699138,0.0108736610147683,0.272312090599059
CASQ2,Calsequestrin-2,Blood and urine assays,X30650.Aspartate aminotransferase,47394,0.00636285893416238,0.00376908894379026,-0.00102455539566652,0.0137502732639913,0.0913953923986613
CASQ2,Calsequestrin-2,Blood and urine assays,X30660.Direct bilirubin,46147,-0.00324892256493448,0.00385215037996308,-0.0107991373096621,0.00430129217979314,0.399013520703577
CASQ2,Calsequestrin-2,Blood and urine assays,X30670.Urea,47455,-0.00173677694762399,0.00376523067711394,-0.00911662907476731,0.00564307517951933,0.644612323487921
CASQ2,Calsequestrin-2,Blood and urine assays,X30680.Calcium,46018,-0.00251939497901143,0.00379224314678253,-0.00995219154670519,0.00491340158868233,0.506472042444544
CASQ2,Calsequestrin-2,Blood and urine assays,X30690.Cholesterol,47468,0.00252770624344918,0.0035859165415866,-0.00450069017806055,0.00955610266495892,0.480882269179028
CASQ2,Calsequestrin-2,Blood and urine assays,X30700.Creatinine,47461,0.00475455096337221,0.00473768475147824,-0.00453131114952514,0.0140404130762696,0.315603611999441
CASQ2,Calsequestrin-2,Blood and urine assays,X30710.C-reactive protein,47398,0.00480054482605706,0.00395074272104053,-0.00294291090718238,0.0125440005592965,0.224343471256267
CASQ2,Calsequestrin-2,Blood and urine assays,X30720.Cystatin C,47475,0.00247643712935305,0.00434024145752345,-0.00603043612739291,0.010983310386099,0.568293958246836
CASQ2,Calsequestrin-2,Blood and urine assays,X30730.Gamma glutamyltransferase,47457,-0.00139857886555275,0.00431515843982288,-0.0098562894076056,0.0070591316765001,0.745859603065596
CASQ2,Calsequestrin-2,Blood and urine assays,X30740.Glucose,45998,-0.00135361183238766,0.00362643764075265,-0.00846142960826285,0.00575420594348752,0.708957907669581
CASQ2,Calsequestrin-2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47400,-0.00212404220441583,0.00365837761028831,-0.00929446232058092,0.00504637791174926,0.561519212456404
CASQ2,Calsequestrin-2,Blood and urine assays,X30760.HDL cholesterol,46007,-0.00632281082226242,0.00428166262971866,-0.014714869576511,0.00206924793198615,0.139769175551464
CASQ2,Calsequestrin-2,Blood and urine assays,X30770.IGF-1,47383,-0.00580218622092032,0.00380257617645747,-0.013255235526777,0.00165086308493632,0.127062400962461
CASQ2,Calsequestrin-2,Blood and urine assays,X30780.LDL direct,47423,0.00338072184509194,0.00358051857462931,-0.0036370945611815,0.0103985382513654,0.345080115539615
CASQ2,Calsequestrin-2,Blood and urine assays,X30790.Lipoprotein A,43660,-0.00384853954351647,0.00392796963425523,-0.0115473600266567,0.00385028093962378,0.327211287933129
CASQ2,Calsequestrin-2,Blood and urine assays,X30810.Phosphate,45982,-0.00531794141801052,0.00369533160310112,-0.0125607913600887,0.00192490852406767,0.150140987673176
CASQ2,Calsequestrin-2,Blood and urine assays,X30830.SHBG,45900,0.000728987261303888,0.00490371075993211,-0.00888228582816305,0.0103402603507708,0.881823397842671
CASQ2,Calsequestrin-2,Blood and urine assays,X30840.Total bilirubin,47386,-0.00220554034670075,0.00389325395561447,-0.00983631809970511,0.00542523740630361,0.571058609187522
CASQ2,Calsequestrin-2,Blood and urine assays,X30850.Testosterone,47282,0.00317529980778145,0.00610902725823375,-0.0087983936183567,0.0151489932339196,0.603228827489058
CASQ2,Calsequestrin-2,Blood and urine assays,X30860.Total protein,45997,0.0104584592583647,0.00376892752368151,0.00307136131194891,0.0178455572047804,0.00552747930982031
CASQ2,Calsequestrin-2,Blood and urine assays,X30870.Triglycerides,47447,0.0032970610498242,0.00373249751988053,-0.00401863408914164,0.01061275618879,0.37706434405383
CASQ2,Calsequestrin-2,Blood and urine assays,X30880.Urate,47443,0.00400698418210559,0.00450529940142259,-0.00482340264468268,0.0128373710088939,0.373802969780626
CASQ2,Calsequestrin-2,Blood and urine assays,X30890.Vitamin D,46904,-0.00721650763238393,0.00402000433372855,-0.0150957161264919,0.000662700861724034,0.072646419806108
CASQ2,Calsequestrin-2,Physical measures,X3137.Number of measurements made,46378,-0.0144307040841443,0.0362027333397675,-0.0853880614300885,0.0565266532618,0.690186752624261
CASQ2,Calsequestrin-2,Physical measures,X3143.Ankle spacing width,39730,0.000809749439240176,0.00657822189721291,-0.0120835654792971,0.0137030643577775,0.902033706214826
CASQ2,Calsequestrin-2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39730,0.0020998604734592,0.00475422136503064,-0.00721841340200085,0.0114181343489193,0.658726932302469
CASQ2,Calsequestrin-2,Physical measures,X3146.Speed of sound through heel,39730,0.0044168168625983,0.00462377557003616,-0.00464578325467258,0.0134794169798692,0.339476925705715
CASQ2,Calsequestrin-2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39730,0.00366789739853401,0.00465893314377229,-0.00546361156325967,0.0127994063603277,0.431133167080388
CASQ2,Calsequestrin-2,Physical measures,X3148.Heel bone mineral density (BMD),39711,0.00311299230811401,0.00469790777447681,-0.00609490692986054,0.0123208915460886,0.50757888547344
CASQ2,Calsequestrin-2,Health and medical history,X3526.Mother's age at death,40385,0.00309588448305622,0.00469221680905027,-0.00610086046268231,0.0122926294287948,0.509400571068807
CASQ2,Calsequestrin-2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32259,-0.0150142532444801,0.0085645343263034,-0.0318007405240347,0.00177223403507458,0.0796732262932347
CASQ2,Calsequestrin-2,Physical measures,X4100.Ankle spacing width (left),35021,0.0042556619913196,0.0086923387478092,-0.0127813219543864,0.0212926459370256,0.624442418587672
CASQ2,Calsequestrin-2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35019,0.00280163103115674,0.00627689518885313,-0.00950108353899539,0.0151043456013089,0.655366534578642
CASQ2,Calsequestrin-2,Physical measures,X4103.Speed of sound through heel (left),35021,0.00383809073113474,0.00601660983733997,-0.0079544645500516,0.0156306460123211,0.52355121236002
CASQ2,Calsequestrin-2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35021,0.00358034447387795,0.00609864788110606,-0.00837300537308994,0.0155336943208458,0.557176095525919
CASQ2,Calsequestrin-2,Physical measures,X4105.Heel bone mineral density (BMD) (left),35014,0.0042739868855234,0.00611819908875428,-0.00771768332843499,0.0162656570994818,0.484846477162255
CASQ2,Calsequestrin-2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35021,0.00359066211158221,0.00609911803611583,-0.00836360923920482,0.0155449334623692,0.556071000139506
CASQ2,Calsequestrin-2,Physical measures,X4119.Ankle spacing width (right),35013,0.0074267863969018,0.00856219774011691,-0.00935512117372734,0.0242086939675309,0.385759425161801
CASQ2,Calsequestrin-2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35013,0.00545069883850121,0.00630118639560361,-0.00689962649688187,0.0178010241738843,0.38705611029109
CASQ2,Calsequestrin-2,Physical measures,X4122.Speed of sound through heel (right),35013,0.00458023281979271,0.00597691316363529,-0.00713451698093246,0.0162949826205179,0.443513656638519
CASQ2,Calsequestrin-2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35013,0.00520549538640768,0.006089885941758,-0.00673068105943799,0.0171416718322534,0.392706457587663
CASQ2,Calsequestrin-2,Physical measures,X4124.Heel bone mineral density (BMD) (right),35005,0.00504829505712574,0.00610654469209039,-0.00692053253937144,0.0170171226536229,0.408436564994292
CASQ2,Calsequestrin-2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35013,0.00520828197955231,0.00608992418004234,-0.00672796941333069,0.0171445333724353,0.392456132899008
CASQ2,Calsequestrin-2,Physical measures,X4194.Pulse rate,35339,0.00583420378209756,0.00562697545903935,-0.00519466811761957,0.0168630756818147,0.299853385043642
CASQ2,Calsequestrin-2,Physical measures,X4195.Pulse wave reflection index,35339,-0.00752322559147306,0.00589249383612922,-0.0190725135102863,0.00402606232734021,0.201735468734218
CASQ2,Calsequestrin-2,Physical measures,X4196.Pulse wave peak to peak time,35331,0.000681020052788602,0.00653738404903058,-0.0121322526833113,0.0134942927888885,0.917035025049144
CASQ2,Calsequestrin-2,Physical measures,X4198.Position of the pulse wave peak,35339,0.00328130672773971,0.00703660140004143,-0.0105104320163415,0.0170730454718209,0.641001663596299
CASQ2,Calsequestrin-2,Physical measures,X4199.Position of pulse wave notch,35339,0.00528681747363317,0.00570213039121255,-0.00588935809314344,0.0164629930404098,0.353873916413718
CASQ2,Calsequestrin-2,Physical measures,X4200.Position of the shoulder on the pulse waveform,35339,0.00286962944704966,0.00720041023929478,-0.0112431746219681,0.0169824335160674,0.690247062337642
CASQ2,Calsequestrin-2,Physical measures,X4269.Number of triplets attempted (left),35153,0.040031245114534,0.157827711088469,-0.269311068618866,0.349373558847934,0.799782524769516
CASQ2,Calsequestrin-2,Physical measures,X4270.Volume level set by participant (left),35079,0.0566671889223706,0.0469943200681005,-0.0354416784111064,0.148776056255848,0.227926869905944
CASQ2,Calsequestrin-2,Physical measures,X4276.Number of triplets attempted (right),35158,0.233149638872173,0.17799978863677,-0.115729946855896,0.582029224600243,0.190298989818242
CASQ2,Calsequestrin-2,Physical measures,X4277.Volume level set by participant (right),35085,-0.0140153159003343,0.0478531170427817,-0.107807425304186,0.0797767935035179,0.769621734332876
CASQ2,Calsequestrin-2,Cognitive function,X4288.Time to answer,35311,-0.0071796666590263,0.00679616939372663,-0.0205001586707305,0.0061408253526779,0.290810543688136
CASQ2,Calsequestrin-2,Cognitive function,X4290.Duration screen displayed,35311,-0.00952312748723962,0.00625508499570475,-0.0217830940788209,0.00273683910434169,0.127940544726197
CASQ2,Calsequestrin-2,Physical measures,X46.Hand grip strength (left),48340,0.00358486171080798,0.00478779798541361,-0.0057992223406027,0.0129689457622187,0.454017078088285
CASQ2,Calsequestrin-2,Physical measures,X47.Hand grip strength (right),48337,-0.000501127850611905,0.00471552103818449,-0.00974354908545351,0.0087412933842297,0.915367626761192
CASQ2,Calsequestrin-2,Physical measures,X48.Waist circumference,48390,-0.00122228553522422,0.00889970817509993,-0.0186657135584201,0.0162211424879716,0.89076348595744
CASQ2,Calsequestrin-2,Health and medical history,X4803.Tinnitus,35184,-0.00781196686814616,0.0542054917031891,-0.114054730606397,0.0984307968701045,0.885411998010394
CASQ2,Calsequestrin-2,Working and living environment,X4825.Noisy workplace,35254,-0.000363472292586465,0.0513147000099423,-0.100940284312073,0.100213339726901,0.994348683592165
CASQ2,Calsequestrin-2,Working and living environment,X4836.Loud music exposure frequency,35211,-0.0652185759442116,0.0708190131824415,-0.204023841781797,0.0735866898933737,0.35712632305228
CASQ2,Calsequestrin-2,Physical measures,X49.Hip circumference,48384,-0.00244309219597388,0.00654573869330735,-0.0152727400348563,0.0103865556429085,0.70897829648641
CASQ2,Calsequestrin-2,Physical measures,X50.Standing height,48352,-0.00284355570284629,0.004958127336053,-0.0125614852815102,0.0068743738758176,0.566303216456117
CASQ2,Calsequestrin-2,Health and medical history,X5057.Number of older siblings,34477,-0.0847897588602174,0.0513099411046429,-0.185357243425317,0.0157777257048826,0.0984857690062
CASQ2,Calsequestrin-2,Physical measures,X51.Seated height,48268,-0.00258098895470115,0.00432728194126678,-0.011062461559584,0.00590048365018175,0.550884344817237
CASQ2,Calsequestrin-2,Eye measures,X5181.Ever had eye surgery,33154,0.02535180446528,0.110889543376902,-0.191991700553447,0.242695309484007,0.819172886518032
CASQ2,Calsequestrin-2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33144,-0.00514622973839066,0.00754822083156987,-0.0199407425682676,0.00964828309148628,0.495412506358932
CASQ2,Calsequestrin-2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33141,-0.00816016216239686,0.00775743819062156,-0.0233647410160151,0.0070444166912214,0.292894724438764
CASQ2,Calsequestrin-2,Eye measures,X5190.Duration at which refractometer first shown (right),33098,-0.00810708711339091,0.00779988104444729,-0.0233948539605076,0.00718067973372577,0.298681122069472
CASQ2,Calsequestrin-2,Eye measures,X5193.Duration at which refractometer first shown (left),33095,-0.0150118691891877,0.00787689504383549,-0.0304505834751053,0.000426845096729829,0.0567385259491039
CASQ2,Calsequestrin-2,Eye measures,"X5199.logMAR, initial (right)",33124,0.0937137119222823,0.0571788394307523,-0.0183568133619923,0.205784237206557,0.101291572139634
CASQ2,Calsequestrin-2,Eye measures,X5200.Final number of letters displayed (right),33124,-0.16290999673596,0.307665565334673,-0.765934504791919,0.440114511319999,0.59648220328235
CASQ2,Calsequestrin-2,Eye measures,"X5201.logMAR, final (right)",33072,0.01463718715134,0.00748465699735029,-3.27405634665649e-05,0.0293071148661466,0.0505714535750866
CASQ2,Calsequestrin-2,Eye measures,X5202.Number of rounds to result (right),33124,0.0501599240707744,0.0521358734348097,-0.0520263878614525,0.152346236003001,0.33605091680522
CASQ2,Calsequestrin-2,Eye measures,"X5206.logMAR, initial (left)",33120,0.0621269570762632,0.0556545657147052,-0.046955991724559,0.171209905877085,0.264354897296999
CASQ2,Calsequestrin-2,Eye measures,X5207.Final number of letters displayed (left),33120,0.581493478414129,0.50545644318194,-0.409201150222474,1.57218810705073,0.250026700254564
CASQ2,Calsequestrin-2,Eye measures,"X5208.logMAR, final (left)",33081,0.0204036106045831,0.00760715815239386,0.00549358062589117,0.0353136405832751,0.00734169398567063
CASQ2,Calsequestrin-2,Eye measures,X5209.Number of rounds to result (left),33116,-0.0642633713472,0.0536663946263439,-0.169449504814834,0.0409227621204341,0.231190235813334
CASQ2,Calsequestrin-2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",32959,0.0171537714361358,0.00743452045675483,0.00258211134089636,0.0317254315313753,0.0210839672011058
CASQ2,Calsequestrin-2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",32959,0.0208674194585485,0.0073288532771842,0.0065028670352675,0.0352319718818296,0.00442984911801957
CASQ2,Calsequestrin-2,Eye measures,X5256.Corneal hysteresis (right),32959,0.000517671602924018,0.0075782321071535,-0.0143356633270968,0.0153710065329449,0.945541727274578
CASQ2,Calsequestrin-2,Eye measures,X5257.Corneal resistance factor (right),32959,0.0133733930610144,0.00749076216350123,-0.00130850077944796,0.0280552869014769,0.0742792463752568
CASQ2,Calsequestrin-2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",32935,0.0178715716761723,0.00749416312125145,0.00318301195851946,0.0325601313938251,0.0171343010119884
CASQ2,Calsequestrin-2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",32935,0.021954809691519,0.00745054428170674,0.00735174289937376,0.0365578764836642,0.00322855315713586
CASQ2,Calsequestrin-2,Eye measures,X5264.Corneal hysteresis (left),32935,0.00194326609932058,0.00749745706472958,-0.0127517497475494,0.0166382819461906,0.795500932338771
CASQ2,Calsequestrin-2,Eye measures,X5265.Corneal resistance factor (left),32935,0.0121610522539177,0.00747918369101508,-0.00249814778047185,0.0268202522883073,0.104025198444345
CASQ2,Calsequestrin-2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,33681,-0.197693614290685,0.317908238100205,-0.820793760967087,0.425406532385717,0.534063495902755
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48343,-0.014425460413555,0.0194157345010952,-0.0524803000357017,0.0236293792085917,0.457503939276755
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48343,-0.0131926458367599,0.0221971333750329,-0.0566990272518243,0.0303137355783045,0.552291492628056
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48343,-0.00163950505307319,0.0554821197347045,-0.110384459733094,0.107105449626948,0.976426119822733
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48343,0.00639121789256108,0.00882825265649623,-0.0109121573141715,0.0236945930992937,0.46910470509132
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48343,0.00024853012856991,0.00818805482182281,-0.0158000573222028,0.0162971175793426,0.975786019944007
CASQ2,Calsequestrin-2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37270,-0.00178037230242201,0.0105208358446829,-0.0224012105580004,0.0188404659531564,0.86562482093255
CASQ2,Calsequestrin-2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37270,-0.0121554257746923,0.0321367512534211,-0.0751434582313977,0.050832606682013,0.705261088511413
CASQ2,Calsequestrin-2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37270,-0.0262264922272426,0.0202993667787355,-0.0660132511135641,0.0135602666590789,0.196396522921089
CASQ2,Calsequestrin-2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37270,0.01802952529106,0.0122479946631115,-0.00597654424863859,0.0420355948307586,0.1410466546171
CASQ2,Calsequestrin-2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48405,0.00313213224973492,0.018583274602758,-0.0332910859716708,0.0395553504711407,0.866155663816598
CASQ2,Calsequestrin-2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48405,0.00313213224973492,0.018583274602758,-0.0332910859716708,0.0395553504711407,0.866155663816598
CASQ2,Calsequestrin-2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48405,-0.0122372741649811,0.013534624055739,-0.0387651373142296,0.0142905889842674,0.365929066725235
CASQ2,Calsequestrin-2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48405,-0.0129022426365932,0.0238223392847422,-0.0595940276346879,0.0337895423615014,0.588098342465136
CASQ2,Calsequestrin-2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48405,0.000395386936267594,0.0566624258521441,-0.110662967733935,0.11145374160647,0.994432525879319
CASQ2,Calsequestrin-2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48405,0.0341135615185662,0.0393854387206241,-0.043081898373857,0.111309021410989,0.386420297686435
CASQ2,Calsequestrin-2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48405,0.0298101240557814,0.0591511678658502,-0.086126164961285,0.145746413072848,0.614291509972763
CASQ2,Calsequestrin-2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48342,-0.0290206589198302,0.0121055505561853,-0.0527475380099535,-0.005293779829707,0.0165255452057444
CASQ2,Calsequestrin-2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48342,0.0595221723068401,0.0212497676875893,0.017872627639165,0.101171716974515,0.00509823702700691
CASQ2,Calsequestrin-2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48342,0.0113636275668993,0.0109461897476991,-0.0100909043385908,0.0328181594723895,0.299219716126892
CASQ2,Calsequestrin-2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48342,0.0125974747042622,0.0161067242140433,-0.0189717047552626,0.044166654163787,0.434150385578588
CASQ2,Calsequestrin-2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48342,0.0231297500639434,0.0164545069403795,-0.00912108353920035,0.0553805836670872,0.159835289241596
CASQ2,Calsequestrin-2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48342,-0.0047872004392135,0.00930548972823741,-0.0230259603065588,0.0134515594281318,0.606943825529615
CASQ2,Calsequestrin-2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,35665,-0.000805785377935983,0.0183644662510082,-0.036800139229912,0.03518856847404,0.965003355087859
CASQ2,Calsequestrin-2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,35665,-0.0053695394690004,0.0175815108156374,-0.0398293006676496,0.0290902217296488,0.760064192428116
CASQ2,Calsequestrin-2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,35665,-0.0139088547666008,0.0254561505778544,-0.0638029098991954,0.0359852003659938,0.584818682371465
CASQ2,Calsequestrin-2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,35665,0.010328163378245,0.0188489811307642,-0.026615839638053,0.0472721663945429,0.583748494625255
CASQ2,Calsequestrin-2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48304,-0.00824688133032601,0.0323971934557236,-0.0717453805035442,0.0552516178428922,0.799069147753198
CASQ2,Calsequestrin-2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48304,0.00925579415401318,0.0405644471197002,-0.0702505222005992,0.0887621105086256,0.819512536188901
CASQ2,Calsequestrin-2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48304,-0.0141426364079221,0.0758504536219591,-0.162809525506962,0.134524252691118,0.852090503751534
CASQ2,Calsequestrin-2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48304,0.00492479921529675,0.0740360005632997,-0.140185761888771,0.150035360319364,0.946965322471162
CASQ2,Calsequestrin-2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48304,-0.0171283701485718,0.0310581989420628,-0.078002440075015,0.0437456997778714,0.581302219859201
CASQ2,Calsequestrin-2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48304,-0.021022592663895,0.036217071662574,-0.09200805312254,0.0499628677947501,0.561610510034938
CASQ2,Calsequestrin-2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48304,-0.00124217206745423,0.015309965078327,-0.0312497036209752,0.0287653594860668,0.935335516748413
CASQ2,Calsequestrin-2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",34545,0.0349495165907373,0.0256028104359397,-0.0152319918637046,0.0851310250451791,0.172284078032797
CASQ2,Calsequestrin-2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",34545,-0.0138670564168511,0.0249597344521823,-0.0627881359431285,0.0350540231094262,0.578520908266206
CASQ2,Calsequestrin-2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",34545,0.0283028461055744,0.0357719751735896,-0.0418102252346612,0.09841591744581,0.428857887113244
CASQ2,Calsequestrin-2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",34545,-0.000877593000657371,0.0129038282570027,-0.0261690963843827,0.024413910383068,0.945779736403953
CASQ2,Calsequestrin-2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37147,0.0222247522208656,0.0110640147154043,0.000539283378673115,0.043910221063058,0.0445958829129382
CASQ2,Calsequestrin-2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37147,-0.011794736004536,0.0122020179952877,-0.0357106912752999,0.0121212192662279,0.333760506690435
CASQ2,Calsequestrin-2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37147,-0.0034921241595268,0.0108353045156291,-0.0247293210101599,0.0177450726911063,0.747239921326464
CASQ2,Calsequestrin-2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37148,-0.0218042906005105,0.0251256957151675,-0.0710506542022389,0.0274420730012178,0.385523574592944
CASQ2,Calsequestrin-2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37148,0.00281928131807055,0.014986877827827,-0.0265549992244704,0.0321935618606115,0.850789671124063
CASQ2,Calsequestrin-2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37148,-0.0309611418033399,0.0275420119837052,-0.0849434852914021,0.0230212016847224,0.260984212814404
CASQ2,Calsequestrin-2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48342,-0.0185762523746692,0.0239261622383109,-0.0654715303617586,0.0283190256124202,0.437522639225555
CASQ2,Calsequestrin-2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48342,0.021808172315916,0.019149857616277,-0.0157255486119869,0.0593418932438188,0.254793549704323
CASQ2,Calsequestrin-2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48342,-0.0523318815190412,0.0404744541392755,-0.131661811632021,0.0269980485939388,0.196039756829588
CASQ2,Calsequestrin-2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48342,0.0147824894009826,0.021447726499573,-0.0272550545381804,0.0568200333401456,0.49068450340859
CASQ2,Calsequestrin-2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48342,0.00794363955700502,0.0219320797548418,-0.035043236762485,0.050930515876495,0.717211898374038
CASQ2,Calsequestrin-2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48342,-0.0214415280926835,0.0265013981679685,-0.0733842685019019,0.0305012123165348,0.418483724649346
CASQ2,Calsequestrin-2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48342,-0.00640363163077326,0.00773884524632978,-0.0215717683135796,0.00876450505203312,0.407982964495782
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,33311,0.0187536048992165,0.0192695488581226,-0.0190147108627038,0.0565219206611368,0.330491501720884
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,33311,0.0103345291133883,0.0230724624538129,-0.034887497296085,0.0555565555228616,0.654234291386781
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,33311,-0.0443351679017616,0.0172079682700038,-0.0780627857109689,-0.0106075500925542,0.0100127431175015
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,33311,0.0199339459296152,0.0153251082909789,-0.0101032663207034,0.0499711581799339,0.193411877990333
CASQ2,Calsequestrin-2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48430,0.00251147373909179,0.00939252998440455,-0.0158978850303411,0.0209208325085247,0.789171257014627
CASQ2,Calsequestrin-2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48430,-0.0399620777192307,0.0307604666296902,-0.100252592313423,0.0203284368749621,0.193911827849742
CASQ2,Calsequestrin-2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48430,-0.00424291745372576,0.00828600466516797,-0.020483486597455,0.0119976516900035,0.608615911125553
CASQ2,Calsequestrin-2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48430,0.0130982810132311,0.00773935702795544,-0.00207085876156158,0.0282674207880238,0.0905806859731508
CASQ2,Calsequestrin-2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48430,0.0116111902408744,0.0131717005335621,-0.0142053428049073,0.0374277232866561,0.378044128780314
CASQ2,Calsequestrin-2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48430,0.0025327306973038,0.0117031612200576,-0.0204054652940092,0.0254709266886168,0.828667096384037
CASQ2,Calsequestrin-2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48430,0.00575732611620163,0.00834837434474316,-0.010605487599495,0.0221201398318982,0.490432199825189
CASQ2,Calsequestrin-2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48430,0.0258136560221752,0.027313742374423,-0.0277212790316939,0.0793485910760443,0.344629841957034
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42400,0.00865368598121323,0.00861772469262422,-0.00823705441633024,0.0255444263787567,0.315312867300754
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42400,0.0070108884733371,0.00849024628667313,-0.00962999424854225,0.0236517711952164,0.40895567985682
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42400,0.00132840919642809,0.0109632331621891,-0.0201595278014626,0.0228163461943188,0.903558566228762
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42401,0.000964967361976905,0.0170181191622268,-0.0323905461959876,0.0343204809199414,0.954783122244187
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42401,0.00267378124755565,0.00969590440926231,-0.0163301913945985,0.0216777538897098,0.782733475297152
CASQ2,Calsequestrin-2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48245,-0.00276504418845911,0.0089170318164829,-0.0202424265487656,0.0147123381718474,0.756499064113765
CASQ2,Calsequestrin-2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48245,-0.0050362489227972,0.00699410706926198,-0.0187446987785507,0.00867220093295629,0.471490266689444
CASQ2,Calsequestrin-2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48245,0.000175869629066835,0.00790846687753039,-0.0153247254508927,0.0156764647090264,0.982258216064389
CASQ2,Calsequestrin-2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48245,-0.0220420157023051,0.0120483194676653,-0.0456567218589291,0.00157269045431886,0.0673446672908614
CASQ2,Calsequestrin-2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48263,0.00558064313003387,0.00750684267339095,-0.00913276850981239,0.0202940547698801,0.457243888319157
CASQ2,Calsequestrin-2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48263,0.00638896821949859,0.0105139320075402,-0.0142183385152803,0.0269962749542775,0.543415453889055
CASQ2,Calsequestrin-2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48342,-0.00254381918161268,0.00767197979593084,-0.0175808995816371,0.0124932612184118,0.740215443821168
CASQ2,Calsequestrin-2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48342,-0.0104222287948296,0.00963455868530736,-0.0293059638180321,0.00846150622837281,0.279374769387134
CASQ2,Calsequestrin-2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48342,-0.014386738629972,0.0203711812612343,-0.0543142539019913,0.0255407766420472,0.480053472675317
CASQ2,Calsequestrin-2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48342,0.022867185394833,0.0190773519721525,-0.014524424470586,0.060258795260252,0.230676060620652
CASQ2,Calsequestrin-2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48342,0.00516557754305706,0.0228396222503775,-0.0396000820676829,0.049931237153797,0.821073581050512
CASQ2,Calsequestrin-2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48342,-0.0188023402000902,0.0233342077660554,-0.0645373874215587,0.0269327070213784,0.420376889784729
CASQ2,Calsequestrin-2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39730,0.00366429623523344,0.00465894707692596,-0.00546724003554145,0.0127958325060083,0.431587045442534
CASQ2,Calsequestrin-2,Physical activities,X864.Number of days or week walked 10+ minutes,48045,-0.0334767360979142,0.02670318541479,-0.0858149795109026,0.0188615073150741,0.209980408123248
CASQ2,Calsequestrin-2,Physical activities,X874.Duration of walks,45811,-0.00153441139043428,0.0035879229403972,-0.00856674035361278,0.00549791757274423,0.668903972574654
CASQ2,Calsequestrin-2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47530,-0.0259149588131108,0.0262077684874143,-0.0772821850484428,0.0254522674222212,0.322760252773503
CASQ2,Calsequestrin-2,Physical activities,X894.Duration of moderate activity,43503,0.0191337845861132,0.0316792396849217,-0.0429575251963333,0.0812250943685597,0.545862829912625
CASQ2,Calsequestrin-2,Physical activities,X90087.No-wear time bias adjusted average acceleration,32492,-0.00624177498114467,0.00834580726491123,-0.0225995572203707,0.0101160072580813,0.45456958659767
CASQ2,Calsequestrin-2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47462,0.0214916292428268,0.0270748447104422,-0.0315750663896399,0.0745583248752936,0.427330087159531
CASQ2,Calsequestrin-2,Physical activities,X914.Duration of vigorous activity,39909,0.00555982664031298,0.00432003138638951,-0.00290743487701046,0.0140270881576364,0.198124966276558
